AXA/2025/FY/Earnings presentation: Difference between revisions

Content deleted Content added
PlumBot: publish from draft
Migrate infobox: document_type -> document_category; add specific form as document_type
 
(13 intermediate revisions by the same user not shown)
Line 4:
| period = FY
| period_label = FY25
| document_typedocument_category = Analyst presentation
| publication_date = 2026-02-26
| language = English
| pages = 49
| source_url = https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf
| archive_file = File:AXA-2025-FY-Earnings_presentation.md
| intro_sentence = This article summarizes AXA's full-year 2025 earnings presentation, published on 26 February 2026.
}}
Line 19 ⟶ 18:
=== Full Year 2025 earnings presentation ===
 
* ''AXA Full Year 2025'' earnings presentation delivered on February Earnings26, Presentation2026 <sup>p. 1</sup>
* February 26, 2026 <sup>p. 1</sup>
 
=== Important legal information and cautionary statements concerning forward-looking statements and the use of non-GAAP financial measures ===
 
* Certain''Forward-looking statements'' are forward-looking, includinginclude predictions of future events, trends, plans, expectations, or objectives, andbased are identified by words likeon Management'expects',s 'anticipates',current 'may',views 'plan,'and 'target'subject orto conditional verbs such as 'would' and 'could'change <sup>p. 2</sup>.
* Statements regarding expected '''underlyingExpected earningsUEPS per sharegrowth''' ('UEPS') growth for 2026 areis forward-looking statementsprovided providingas one-off guidance forin the context of the lastfinal year of the Group's current strategic plan <sup>p. 2</sup>.
* ''Risk factors'' and uncertainties that may affect AXA's business are described in Part 5 "Risk Factors and Risk Management" of AXA's 2024 Universal Registration Document <sup>p. 2</sup>.
* These statements are based on Management's current views and intentions and are subject to change <sup>p. 2</sup>.
* ''Alternative performance measures'' (APMs) used include "underlying earnings", UEPS ("underlying earnings per share"), "underlying return on equity", "combined ratio", and "debt gearing" <sup>p. 2</sup>.
* Undue reliance should not be placed on forward-looking statements due to known and unknown risks and uncertainties, many outside AXA's control, which could cause actual results to differ materially <sup>p. 2</sup>.
** APMs are defined under ESMA guidelines and the AMF's 2015 position statement, with reconciliations provided in AXA's 2025 Activity Report <sup>p. 2</sup>.
* Each forward-looking statement speaks only at the date of this presentation <sup>p. 2</sup>.
* Refer''Financial to Part 5statements status'Risk Factors and Risk Management' of: AXA's Universalconsolidated Registrationfinancial Documentstatements for the year ended December 31, 20242025 (thewere '2024examined Universalby Registrationthe Document')Board forof aDirectors descriptionon ofFebruary important factors25, risks2026, and uncertaintiesare subject to completion of audit procedures <sup>p. 2</sup>.
* AXA disclaims any obligation to publicly update or revise any forward-looking statements, except as required by applicable laws and regulations <sup>p. 2</sup>.
* This presentation refers to certain non-GAAP financial measures, or alternative performance measures ('APMs'), used by Management for analyzing operating trends, financial performance, and financial position <sup>p. 2</sup>.
* These non-GAAP financial measures generally have no standardized meaning and may not be comparable to similarly labeled measures used by other companies <sup>p. 2</sup>.
* None of these non-GAAP financial measures should be considered in isolation from, or as a substitute for, the Group's consolidated financial statements and related notes prepared in accordance with IFRS <sup>p. 2</sup>.
* '''Underlying earnings''', UEPS ('underlying earnings per share'), '''underlying return on equity''', '''combined ratio''', and '''debt gearing''' are APMs as defined in ESMA's guidelines and the AMF's related position statement issued in 2015 <sup>p. 2</sup>.
* AXA provides a reconciliation of such APMs to the most closely related line item, subtotal, or total in the financial statements of the corresponding period (and/or their calculation methodology) in its Activity Report as of December 31, 2025 ('AXA's 2025 Activity Report'), under the heading 'Use of non-GAAP and alternative performance measures' <sup>p. 2</sup>.
* For further information on non-GAAP financial measures, see the Glossary in AXA's 2025 Activity Report <sup>p. 2</sup>.
* AXA's Activity Report as of December 31, 2025 is available on the AXA Group website (www.axa.com) <sup>p. 2</sup>.
* AXA's consolidated financial statements for the year ended December 31, 2025 were examined by the Board of Directors on February 25, 2026, and are subject to completion of an audit procedure by AXA's statutory auditors <sup>p. 2</sup>.
 
=== Table of contents ===
 
* '''1. FY25 Highlights''': presented by Thomas Buberl, Group CEO, starting on page 04 <sup>p. 3, 4</sup>.
* '''2. FY25 Business Performance''': presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology, starting on page 09 <sup>p. 3, 9</sup>.
* '''3. FY25 Financial Performance''': presented by Alban de Mailly Nesle, Group CFO, starting on page 13 <sup>p. 3, 13</sup>.
 
== FY25 Highlights ==
 
* Section divider slide for ''FY25 Highlights'', presented by Thomas Buberl, Group CEO <sup>p. 4</sup>.
=== 1 FY25 Highlights ===
 
* FY25 Highlights <sup>p. 4</sup>
* Thomas Buberl, Group CEO <sup>p. 4</sup>
 
=== Full Year 2025 | Excellent performance ===
 
<div style="overflow-x:auto">
* '''Revenues''' +6% vs. FY24 <sup>p. 5</sup>
{| class="wikitable fintable"
* '''Underlying EPS''' +8% vs. FY24 <sup>p. 5</sup>
*|+ '''ROE'''Key FY25:financial 16%highlights, FY25 <sup>p. 5</sup>
! style="text-align:left" | Metric
* '''Solvency II ratio''' FY25: 224% <sup>p. 5</sup>
! class="col-m" style="text-align:right" | Value
* Delivering value for shareholders with '''DPS''' +8% growth and EUR 1.25bn annual share buy back <sup>p. 5</sup>.
|-
** DPS growth is based on the dividend proposed by AXA's Board of Directors on February 25, 2026, and is subject to approval by the Shareholders' Annual General Meeting on April 30, 2026 <sup>p. 5</sup>.
| style="text-align:left" | Revenues growth vs. FY24
** The annual share buy back follows AXA's Board of Directors' approval on February 25, 2026, and is expected to commence as soon as reasonably practicable, subject to market conditions <sup>p. 5</sup>.
| style="text-align:right" | +6%
* Confident to deliver '''underlying EPS growth''' at the upper end of 6%-8% target range for 2026 <sup>p. 5</sup>.
|-
| style="text-align:left" | Underlying EPS growth vs. FY24
| style="text-align:right" | +8%
|-
| style="text-align:left" | Return on equity
| style="text-align:right" | 16%
|-
| style="text-align:left" | Solvency II ratio
| style="text-align:right" | 224%
|-
| style="text-align:left" | DPS growth
| style="text-align:right" | +8%
|-
| style="text-align:left" | Annual share buyback
| style="text-align:right" | EUR 1.25bn
|-
| style="text-align:left" | Underlying EPS outlook for 2026
| style="text-align:right" | Upper end of 6%-8% target range
|}
</div>
* Dividend proposal based on Board of Directors' recommendation on February 25, 2026, subject to Shareholders' Annual General Meeting approval on April 30, 2026
* Share buyback approved by the Board of Directors on February 25, 2026, expected to commence as soon as reasonably practicable, subject to market conditions
 
=== Executing the plan on growth, margin and efficiency ===
Line 68 ⟶ 76:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earnings and top line growth, FY24 vs FY25 <sup>p. 6</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change (constant FX)
! class="col-s" style="text-align:right" | Change (excluding AXA IM)
|-
| style="text-align:left" | Underlying earnings
Line 78 ⟶ 87:
| style="text-align:right" | 8.4
| style="text-align:right" | +6%
|-
| style="text-align:left" | Underlying earnings (excl. AXA IM)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | +9%
|-
| style="text-align:left" | Top line growth
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | +6%
|-
| style="text-align:left" | P&C
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | +5%
|-
| style="text-align:left" | Life
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | +9%
|-
| style="text-align:left" | Health
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | +5%
|}
</div>
* High organic growth: +6% top line growth, well balanced across lines (P&C: +5%, Life: +9%, Health: +5%)
* '''Record profitability''': Further margin expansion in P&C and L&H; improvement in efficiency <sup>p. 6</sup>
* Record profitability: Further margin expansion in P&C and L&H; improvement in efficiency
* '''Scaling the business''': Continued investments in growth and technology <sup>p. 6</sup>
* Scaling the business: Continued investments in growth and technology
* Consistent earnings growth while enhancing reserve prudence <sup>p. 6</sup>
* Consistent earnings growth while enhancing reserve prudence
* Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX <sup>p. 6</sup>.
 
=== Diversified franchise, well positioned in an attractive industry ===
Line 114 ⟶ 99:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 grossGross written premium split (FY25, excluding AXA IM and holdings) <sup>p. 7</sup>
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | Share
Line 125 ⟶ 110:
|-
| style="text-align:left" | Large & Specialty
| style="text-align:right" | 17%
|-
| style="text-align:left" | Retail
| style="text-align:right" | 17%
|-
| style="text-align:left" | SME & Mid-market
| style="text-align:right" | 16%
|-
| style="text-align:left" | Retail
| style="text-align:right" | 17%
|}
</div>
 
* '''Secular trends fueling demand across businesses''': <sup>p. 7</sup>
** Protection''Secular trends'' fuel demand across businesses, driven by protection gaps and emerging corporate risks, (relevantas forwell SMEas &demographics Mid-marketdriving anddemand Largefor &private Specialtyretirement segments) <sup>p.and 7</sup>healthcare
* ''Our right to win'' is supported by four strategic pillars:
** Demographics driving demand for private retirement and healthcare (relevant for Life and Health segments) <sup>p. 7</sup>
** Leading brand & high customer NPS
* '''Our right to win''': <sup>p. 7</sup>
** Strong and diversified distribution
** Leading brand & high customer NPS <sup>p. 7</sup>
** Technical expertise to price & underwrite risks
** Strong and diversified distribution <sup>p. 7</sup>
** Scale offering cost advantage
** Technical expertise to price & underwrite risks <sup>p. 7</sup>
** Scale offering cost advantage <sup>p. 7</sup>
* Pie chart represents FY25 gross written premium split excluding AXA IM and holdings <sup>p. 7</sup>.
 
=== Laying the foundation for the next plan ===
 
* ''Strategic pillars'' established to lay the foundation for the next plan:
* (icon) '''Clear tech and AI roadmap''' <sup>p. 8</sup>
* (icon)* '''DrivingClear efficiency'tech'' and AI roadmap <sup>p. 8</sup>
** (icon)''Driving efficiency'''Enhancing capitalacross allocation discipline'''operations <sup>p. 8</sup>
* (icon)* '''BuildingEnhancing resilience'capital'' allocation discipline <sup>p. 8</sup>
** Confidence''Building inresilience'' sustainingacross earningsthe growthbusiness <sup>p. 8</sup>
* ''Earnings growth'' outlook supported by strong foundations, providing confidence in sustaining earnings growth <sup>p. 8</sup>
 
== Business Performance ==
* Guillaume Borie <sup>p. 9</sup>
* Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 9</sup>
* FY25 Business Performance <sup>p. 9</sup>
 
=== FY25 business performance ===
== Strong delivery across our businesses ==
 
* ''Section 2'': FY25 Business Performance presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 9</sup>.
 
=== Strong delivery across our businesses ===
 
* ''Premium growth basis'': change for gross written premiums is at constant scope and FX <sup>p. 10</sup>.
* ''Earnings growth basis'': change for underlying earnings is at constant FX <sup>p. 10</sup>.
* ''Total GWP definition'': FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers <sup>p. 10</sup>.
 
<div style="overflow-x:auto">
{| class="wikitable"
|+ Gross written premiums and underlying earnings by region, FY25 <sup>p. 10</sup>
! style="text-align:left" | Region (share of total GWP¹)
! class="col-m" style="text-align:right" | GWP share
! class="col-m" style="text-align:right" | Gross written premiums
! class="col-m" style="text-align:right" | Underlying earnings
|-
| style="text-align:left" | ''France'' (27% of total GWP¹)
| class="col-m" style="text-align:right" | 27%
| class="col-m" style="text-align:right" | +6% to EUR 31bn
| class="col-m" style="text-align:right" | +7% to EUR 2.2bn
|-
| style="text-align:left" | ''Europe'' (38% of total GWP¹)
| class="col-m" style="text-align:right" | 38%
| class="col-m" style="text-align:right" | +6% to EUR 43bn
| class="col-m" style="text-align:right" | +9% to EUR 3.5bn
|-
| style="text-align:left" | ''AXA XL'' (17% of total GWP¹)
| class="col-m" style="text-align:right" | 17%
| class="col-m" style="text-align:right" | +4% to EUR 19bn
| class="col-m" style="text-align:right" | +9% to EUR 1.9bn
|-
| style="text-align:left" | ''Asia, Africa & EME-LATAM'' (18% of total GWP¹)
| class="col-m" style="text-align:right" | 18%
| class="col-m" style="text-align:right" | +13% to EUR 20bn
| class="col-m" style="text-align:right" | +6% to EUR 1.5bn
|}
</div>
* Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX <sup>p. 10</sup>.
* ¹ FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers <sup>p. 10</sup>.
 
=== P&C | Strong margins, confidence in sustaining growth ===
 
* Underlying''Gross earningswritten +9% to EUR 5.9bnpremiums'' (changeGWP) FY25reached vs.EUR FY24 at constant FX)58bn <sup>p. 11</sup>.
* (donut) ''GWP mix'': Retail, AXA XL (Large & Specialty), SME & Mid-market — shares not labeled <sup>p. 11</sup>.
<div style="overflow-x:auto">
** AXA XL GWP includes AXA XL Re premiums of EUR 2.6bn <sup>p. 11</sup>.
{| class="wikitable fintable"
|* ''Underlying earnings'' +9% GWPat split,constant EURFX 58bnto totalEUR 5.9bn <sup>p. 11</sup>.
* ''Retail and SME & Mid-market'' strategic outlook:
! style="text-align:left" | Segment
** ''2025'': Growing volumes while expanding margins <sup>p. 11</sup>.
! class="col-s" style="text-align:right" | Share
** ''Beyond 2025'': Investing to improve customer retention and expanding distribution footprint <sup>p. 11</sup>.
|-
* ''AXA XL (Large & Specialty)'' strategic outlook:
| style="text-align:left" | Retail
** ''2025'': Profitable growth with stable margins <sup>p. 11</sup>.
| style="text-align:right" | 34%
** ''Beyond 2025'': Capitalizing on attractive growth opportunities and continued cycle management <sup>p. 11</sup>.
|-
* ''Earnings drivers'' supporting performance:
| style="text-align:left" | SME & Mid-market
** Continued progress on efficiency <sup>p. 11</sup>.
| style="text-align:right" | 33%
** Higher investment income <sup>p. 11</sup>.
|-
** Data & AI to further enhance customer experience and technical excellence <sup>p. 11</sup>.
| style="text-align:left" | AXA XL (Large & Specialty)
| style="text-align:right" | 33%
|}
</div>
* (diagram) '''2025 Strategic Focus''' <sup>p. 11</sup>
** '''Retail and SME & Mid-market''': Growing volumes while expanding margins <sup>p. 11</sup>
** '''AXA XL''' (Large & Specialty): Profitable growth with stable margins <sup>p. 11</sup>
* (diagram) '''Beyond 2025 Strategic Focus''' <sup>p. 11</sup>
** '''Retail and SME & Mid-market''': Investing to improve customer retention & expanding distribution footprint <sup>p. 11</sup>
** '''AXA XL''' (Large & Specialty): Capitalizing on attractive growth opportunities and continued cycle management <sup>p. 11</sup>
* (diagram) '''Additional Strategic Initiatives''' <sup>p. 11</sup>
** Continued progress on efficiency <sup>p. 11</sup>
** Higher investment income <sup>p. 11</sup>
** Data & AI to further enhance customer experience & technical excellence <sup>p. 11</sup>
* '''AXA XL''' (Large & Specialty): 33% (includes AXA XL Re premiums of EUR 2.6bn) <sup>p. 11</sup>
 
=== L&H | Good momentum, well positioned to capture growth opportunities ===
 
* Underlying''Gross earningswritten +7% to EUR 3.5bnpremiums'' (changeGWP) FY25reached vs.EUR FY24 at constant FX)57bn <sup>p. 12</sup>.
* (donut) ''GWP mix'': Short-term and Long-term segments — shares not labeled <sup>p. 12</sup>.
<div style="overflow-x:auto">
* ''Underlying earnings'' +7% LFL to EUR 3.5bn (change FY25 vs. FY24 at constant FX) <sup>p. 12</sup>.
{| class="wikitable fintable"
* ''Long-term business'' strategic priorities:
|+ GWP split, EUR 57bn total <sup>p. 12</sup>
** ''2025'': Accelerating net flows in Savings at attractive margins <sup>p. 12</sup>.
! style="text-align:left" | Segment
** ''Beyond 2025'': Capturing savings & retirement opportunity, sourcing best asset management products for our customers <sup>p. 12</sup>.
! class="col-s" style="text-align:right" | Share
* ''Short-term business'' strategic priorities:
|-
** ''2025'': Growing technical results while absorbing Mexico VAT impact <sup>p. 12</sup>.
| style="text-align:left" | Short-term
** ''Beyond 2025'': Capitalizing on demand for health & protection while further improving our margins <sup>p. 12</sup>.
| style="text-align:right" | 28%
* ''Strategic levers'' for growth and efficiency:
|-
** Focus on cost reduction <sup>p. 12</sup>.
| style="text-align:left" | Long-term
** Increasing penetration of Protection riders in Savings offerings <sup>p. 12</sup>.
| style="text-align:right" | 72%
** Leveraging AI to reduce claims leakage & improve customer outcomes in Health <sup>p. 12</sup>.
|}
 
</div>
== Financial Performance ==
* (diagram) '''2025 Strategic Focus''' <sup>p. 12</sup>
 
** '''Long-term business''': Accelerating net flows in Savings at attractive margins <sup>p. 12</sup>
=== FY25 financial performance ===
** '''Short-term business''': Growing technical results while absorbing Mexico VAT impact <sup>p. 12</sup>
 
* (diagram) '''Beyond 2025 Strategic Focus''' <sup>p. 12</sup>
** '''Long-termSection business'3'': CapturingFY25 savingsFinancial &Performance retirementpresented opportunity,by sourcingAlban bestde assetMailly management products forNesle, ourGroup customersCFO <sup>p. 1213</sup>
** '''Short-term business''': Capitalizing on demand for health & protection while further improving our margins <sup>p. 12</sup>
* (diagram) '''Additional Strategic Initiatives''' <sup>p. 12</sup>
** Focus on cost reduction <sup>p. 12</sup>
** Increasing penetration of Protection riders in Savings offerings <sup>p. 12</sup>
** Leveraging AI to reduce claims leakage & improve customer outcomes in Health <sup>p. 12</sup>
* '''FY25 Financial Performance''' <sup>p. 13</sup>
* Alban de Mailly Nesle <sup>p. 13</sup>
* Group CFO <sup>p. 13</sup>
 
=== P&C | Continued disciplined growth ===
Line 257 ⟶ 216:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ P&C GWP & other revenues by linesegment, FY24 vs FY25 <sup>p. 14</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
! class="col-s" style="text-align:right" | o/w pricing
! class="col-s" style="text-align:right" | o/w volume
|-
| style="text-align:left" | Commercial lines
| style="text-align:right" | —
| style="text-align:right" | 35.8
| style="text-align:right" | 35.8+4%
| style="text-align:right" | +2%
| style="text-align:right" | +2%
|-
| style="text-align:left" | AXA XL Reinsurance
| style="text-align:right" | —
| style="text-align:right" | 2.6
| style="text-align:right" | 2.6+8%
| style="text-align:right" | +0.3%
| style="text-align:right" | +7%
|-
| style="text-align:left" | Retail lines
| style="text-align:right" | 18.1
| style="text-align:right" | 19.7
| style="text-align:right" | +7%
| style="text-align:right" | +5%
| style="text-align:right" | +2%
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | 56.5
| style="text-align:right; font-weight:bold" | 58.0
| style="text-align:right; font-weight:bold" | +5%
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
|}
</div>
* Continued pricing momentum and volume growth in Mid-market and SME
* Commercial lines: +4% change (o/w pricing +2%, o/w volume +2%) <sup>p. 14</sup>
* Growing in lines of business with attractive margins while remaining focused on retention at AXA XL Insurance
** Continued pricing momentum and volume growth in Mid-market and SME <sup>p. 14</sup>
* Growth supported by alternative capital
* AXA XL Reinsurance: +8% change (o/w pricing +0.3%, o/w volume +7%) <sup>p. 14</sup>
* Favorable pricing trends and strong growth in net new contracts (+1.7m in FY25)
** Growing in lines of business with attractive margins while remaining focused on retention at AXA XL Insurance <sup>p. 14</sup>
** Growth supported by alternative capital <sup>p. 14</sup>
* Retail lines: +7% change (o/w pricing +5%, o/w volume +2%) <sup>p. 14</sup>
** Favorable pricing trends and strong growth in net new contracts (+1.7m in FY25) <sup>p. 14</sup>
* Change at constant scope and FX <sup>p. 14</sup>
 
=== P&C | Delivering further margin expansion while enhancing reserve prudence ===
Line 292 ⟶ 262:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Combined ratio breakdownbridge, FY24 vs FY25 <sup>p. 15</sup>
! style="text-align:left" | %Combined ratio
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Undiscounted CY loss ratio (ex Nat Cat)
| style="text-align:right" | 67.4%
| style="text-align:right" | 67.0%
|-
| style="text-align:left" | Expense ratio
| style="text-align:right" | 25.0%
| style="text-align:right" | 24.8%
|-
| style="text-align:left" | Nat Cat
| style="text-align:right" | 3.8%
| style="text-align:right" | 3.4%
|-
| style="text-align:left" | Prior year reserve development
| style="text-align:right" | -1.6%
| style="text-align:right" | -1.1%
|-
| style="text-align:left" | Discount
| style="text-align:right" | -3.6%
| style="text-align:right" | -3.5%
|-
| style="text-align:left; font-weight:bold" | Total Combinedcombined Ratioratio
| style="text-align:right; font-weight:bold" | 91.0%
| style="text-align:right; font-weight:bold" | 90.6%
|}
</div>
* BetterUndiscounted undiscounted current yearCY loss ratio excluding(ex Nat Cat) improved from: <sup>p. 15</sup>
** Margin expansion in Commercial lines SME & mid-market business and Personal lines reflecting favorable pricing environment <sup>p. 15</sup>
** Stable AXA XL Insurance margins at attractive levels reflecting disciplined cycle management <sup>p. 15</sup>
* ImprovementExpense inratio expense ratioimproved reflecting the impact of efficiency measures, while continuing to invest in growth initiatives and technology <sup>p. 15</sup>
* Nat Cat charges below normalized load <sup>p. 15</sup>
* Lower reliance on priorPrior year reserve development <sup>p.shows 15</sup>lower reliance
* TakingReserve prudence enhanced by taking advantage of a good year to enhance reserve prudence <sup>p. 15</sup>
 
=== P&C | Earnings growth from higher underwriting and financial result ===
Line 334 ⟶ 304:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earnings walkbridge, FY24 to FY25 <sup>p. 16</sup>
! style="text-align:left" | EUR million
! class="col-s" style="text-align:right" | Underlying Earningsearnings
|-
| style="text-align:left" | FY24
Line 363 ⟶ 333:
|}
</div>
* Underlying Earningsearnings grew +9% (change at constant FX) <sup>p.to 16</sup>EUR 5,872m.
* Better underwritingUnderwriting result improved from strong volume growth and improved all-year combined ratio while enhancing reserve prudence <sup>p. 16</sup>
* IncreaseInvestment inincome investment incomeincreased reflecting higher volumes and better reinvestment yields on fixed income assets <sup>p. 16</sup>
* HigherInsurance finance expenses impacted by higher unwind of discount of claims reserves, in line with guidance <sup>p. 16</sup>
* Unfavorable forexForex impact was unfavorable, notably due to USD depreciation vs. EUR <sup>p. 16</sup>
 
=== Life & Health | Strong growth in premiums, positive net flows ===
Line 373 ⟶ 343:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Life GWP &and other revenues by line, FY24 vs FY25 <sup>p. 17</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left" | Life GWP
| style="text-align:right" | 34.5
| style="text-align:right" | 37.5
| style="text-align:right" | +9%
|-
| style="text-align:left" | Protection
| style="text-align:right" | —
| style="text-align:right" | 17.3
| style="text-align:right" | 19.0
| style="text-align:right" | +11%
|-
| style="text-align:left" | Unit-linked
| style="text-align:right" | —
| style="text-align:right" | 9.3
| style="text-align:right" | 10.5
| style="text-align:right" | +13%
|-
| style="text-align:left" | Capital light G/A
| style="text-align:right" | 6.0
| style="text-align:right" | 69.10
| style="text-align:right" | +7%
|-
| style="text-align:left" | Traditional G/A
| style="text-align:right" | 1.9
| style="text-align:right" | 1.9
| style="text-align:right" | -7%
|-
| style="text-align:left; font-weight:bold" | TotalHealth GWP
| style="text-align:right; font-weight:bold" | 3417.5
| style="text-align:right; font-weight:bold" | 3719.50
| style="text-align:right; font-weight:bold" | +95%
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Health GWP & other revenues by line, FY24 vs FY25 <sup>p. 17</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Individual
| style="text-align:right" | —
| style="text-align:right" | 10.5
| style="text-align:right" | 11.1
| style="text-align:right" | +6%
|-
| style="text-align:left" | Group
| style="text-align:right" | 7.0
| style="text-align:right" | 78.95
| style="text-align:right" | +4%
|-
| style="text-align:left; font-weight:bold" | TotalEmployee Benefits GWP
| style="text-align:right; font-weight:bold" | 17.5
| style="text-align:right; font-weight:bold" | 1912.09
| style="text-align:right; font-weight:bold" | +54%
|}
</div>
Line 433 ⟶ 398:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Net flows by segment, FY24 vs FY25 <sup>p. 17</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | 1.5
| style="text-align:right; font-weight:bold" | 5.4
|-
| style="text-align:left" | Protection
| style="text-align:right" | +4.9
| style="text-align:right" | 4.9
|-
| style="text-align:left" | Health
| style="text-align:right" | +2.7
| style="text-align:right" | 2.7
|-
| style="text-align:left" | Unit-Linked
| style="text-align:right" | +1.5
| style="text-align:right" | 1.5
|-
| style="text-align:left" | Capital light G/A
| style="text-align:right" | +1.2
| style="text-align:right" | 1.2
|-
| style="text-align:left" | Traditional G/A
| style="text-align:right" | —
| style="text-align:right" | -5.0
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | +5.4
|}
</div>
 
* Employee Benefits (including both short-term and long-term Employee Benefits GWP and other revenues) FY25: EUR 12.9bn (+4% vs. FY24) <sup>p. 17</sup>
 
=== Life & Health | Strong volume growth in Savings and Protection impacted by higher interest rates on discounting ===
 
* PVEP was impacted by higher interest rates on discounting despite strong growth in Life volumes (change at constant scope and FX) <sup>p. 18</sup>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ PVEP trend by segment, FY24 vs FY25 <sup>p. 18</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left; font-weight:bold" | Total PVEP
| style="text-align:right; font-weight:bold" | 50.9
| style="text-align:right; font-weight:bold" | 49.4
| style="text-align:right; font-weight:bold" | -2%
|-
| style="text-align:left" | Protection & Health
| style="text-align:right" | 39.4
| style="text-align:right" | 31.4
| style="text-align:right" | -4%
|-
| style="text-align:left" | Unit-Linked
| style="text-align:right" | 8.5
| style="text-align:right" | 8.5
| style="text-align:right" | +18%
|-
| style="text-align:left" | Capital-light G/A
| style="text-align:right" | 2.0
| style="text-align:right" | 7.8
| style="text-align:right" | -10%
|-
| style="text-align:left" | Traditional G/A
| style="text-align:right" | 1.0
| style="text-align:right" | 1.7
| style="text-align:right" | -10%
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | 50.9
| style="text-align:right; font-weight:bold" | 49.4
| style="text-align:right; font-weight:bold" | -2%
|}
</div>
 
* NB CSM was driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits <sup>p. 18</sup>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ NB CSM (pre-tax)and NBV, FY24 vs FY25 <sup>p. 18</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left" | NB CSM (pre-tax)
| style="text-align:right" | 2.2
| style="text-align:right" | 2.2
| style="text-align:right" | +3%
|}
</div>
 
* NBV was broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France <sup>p. 18</sup>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ NBV (post-tax) and margin, FY24 vs FY25 <sup>p. 18</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | NBV (post-tax)
| style="text-align:right" | 2.3
| style="text-align:right" | 2.2
| style="text-align:right" | stable
|-
| style="text-align:left" | NBV margin
| style="text-align:right" | 4.4%
| style="text-align:right" | 4.5%
| style="text-align:right" | —
|}
</div>
 
* ''PVEP'' impacted by higher interest rates on discounting despite strong growth in Life volumes <sup>p. 18</sup>.
* ''NB CSM'' driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits <sup>p. 18</sup>.
* ''NBV'' broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France <sup>p. 18</sup>.
* ''NBV margin'': 4.4% in FY24 → 4.5% in FY25 <sup>p. 18</sup>
 
=== Life & Health | Growth in new business driving Normalized CSM growth ===
 
* Normalized CSM up by +2%, with CSM release growth reflecting better margins and new business CSM growth impacted by higher rates (change at constant scope and FX) <sup>p. 19</sup>
 
<div style="overflow-x:auto">
Line 545 ⟶ 497:
|+ Contractual Service Margin rollforward, FY24 to FY25 <sup>p. 19</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | CSMValue
|-
| style="text-align:left" | FY24
Line 573 ⟶ 525:
</div>
 
* ''Normalized CSM'' up by +2%, with CSM release growth reflecting better margins and new business CSM growth impacted by higher rates <sup>p. 19</sup>
* Economic variance reflecting government spreads tightening and positive equity market returns <sup>p. 19</sup>
* Operating''Economic variance'' drivenreflecting bygovernment betterspreads marginstightening and netpositive flowsequity thatmarket were more than offset by a reduction in the duration of Group Life business in Switzerlandreturns <sup>p. 19</sup>
* ''Operating variance'' driven by better margins and net flows that were more than offset by a reduction in the duration of Group Life business in Switzerland <sup>p. 19</sup>
* FX impact mainly from JPY and HKD depreciation <sup>p. 19</sup>
* ''FX impact'' mainly from JPY and HKD depreciation <sup>p. 19</sup>
 
* (waterfall) ''Contractual Service Margin rollforward'' (in EUR billion): FY24 EUR 33.6bn (o/w Life EUR 25.8bn, o/w Health EUR 7.7bn) → New business CSM +EUR 2.2bn → Underlying return on in-force +EUR 1.3bn → CSM release -EUR 3.0bn (Normalized CSM growth +2%) → Economic variance +EUR 0.6bn → Operating variance -EUR 0.3bn → Affiliates, FX & other -EUR 1.4bn → FY25 EUR 33.0bn (o/w Life EUR 25.4bn, o/w Health EUR 7.6bn) <sup>p. 19</sup>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ CSM by segment, FY24 vs FY25 <sup>p. 19</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Life
| style="text-align:right" | 25.8
| style="text-align:right" | 25.4
|-
| style="text-align:left" | Health
| style="text-align:right" | 7.7
| style="text-align:right" | 7.6
|}
</div>
 
=== Life & Health | Strong momentum in both short-term and long-term business ===
Line 598 ⟶ 535:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying Earningsearnings walkbridge, FY24 to FY25 <sup>p. 20</sup>
! style="text-align:left" | EUR million
! class="col-s" style="text-align:right" | Underlying Earningsearnings
|-
| style="text-align:left" | FY24 start
| style="text-align:right" | 3,323
|-
Line 617 ⟶ 554:
| style="text-align:right" | -27
|-
| style="text-align:left" | FY25 end
| style="text-align:right" | 3,501
|}
</div>
 
* ''Underlying Earningsearnings'' +7% (changeLFL atto constantEUR FX)3,501m <sup>p. 20</sup>
* Strong short''Short-term technical margin'': reflectingEUR underwriting415m andin claimsFY24 initiativesto thatEUR more than offset the impact of legislative change on the recoverability of value added tax479m in Mexico (EUR -0.1bn)FY25 <sup>p. 20</sup>
* Higher long''Long-term resultsresult'' from increase inincl. CSM release: (+8%)EUR reflecting growth2,680m in reserveFY24 base, including from favorable equityto marketEUR performance2,804m and betterin marginsFY25 <sup>p. 20</sup>
* Underlying''Financial Earningsresult'': o/wEUR Life:975m in FY24 EUR 2.6bn, FY25to EUR 2.7bn946m (+4%in vs. FY24)FY25 <sup>p. 20</sup>
* Underlying''Tax Earnings& o/w Healthothers'': FY24 EUR 0.7bn,-748m FY25in FY24 to EUR 0.8bn-728m (+17%in vs. FY24)FY25 <sup>p. 20</sup>
* '''Short-termLife technicalunderlying margin'earnings'' +4% to EUR 2.7bn (prior: EUR 479m2.6bn) <sup>p. 20</sup>
* ''Health underlying earnings''Long-term result+17% incl.to CSMEUR release'''0.8bn (prior: EUR 2,804m0.7bn) <sup>p. 20</sup>
* ''Short-term margin'' strong on underwriting and claims initiatives; more than offset legislative change on Mexico VAT recoverability of EUR -0.1bn <sup>p. 20</sup>
* '''Financial result''': EUR 946m <sup>p. 20</sup>
* ''Long-term results'' higher from CSM release increase of +8% on reserve base growth, favorable equity markets, and better margins <sup>p. 20</sup>
* '''Tax & others''': -EUR 728m <sup>p. 20</sup>
 
== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM ==
 
=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM ===
Line 638 ⟶ 573:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ UnderlyingEarnings earningsand bynet segment,income breakdown FY24 vs FY25 <sup>p. 21</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
Line 645 ⟶ 580:
|-
| style="text-align:left" | Property & Casualty
| style="text-align:right" | 5.5
| style="text-align:right" | 5.9
| style="text-align:right" | +9%
|-
| style="text-align:left" | Life & Health
| style="text-align:right" | 3.3
| style="text-align:right" | 3.5
| style="text-align:right" | +7%
|-
| style="text-align:left" | Asset Management
| style="text-align:right" | 0.4
| style="text-align:right" | 0.2
| style="text-align:right" | -57%
|-
| style="text-align:left" | Holdings & other
| style="text-align:right" | —
| style="text-align:right" | -1.2
| style="text-align:right" | stable-1.2
| style="text-align:right" | -
|-
| style="text-align:left; font-weight:bold" | Total''Underlying earnings''
| style="text-align:right; font-weight:bold" | 8.1
| style="text-align:right; font-weight:bold" | 8.4
| style="text-align:right; font-weight:bold" | +6%
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Net income, FY24 vs FY25 <sup>p. 21</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Net income (reported)
| style="text-align:right" | 7.9
| style="text-align:right" | 9.8
| style="text-align:right" | +26%
|-
| style="text-align:left" | Non-financial flows
| style="text-align:right" | -0.5
| style="text-align:right" | +2.1
| style="text-align:right" | —
|-
| style="text-align:left; padding-left:1.5em" | Capitalo/w capital gains from AXA IM disposal
| style="text-align:right" | -
| style="text-align:right" | +2.2
| style="text-align:right" | —
|-
| style="text-align:left" | Financial flows (incl. RCG)
| style="text-align:right" | +0.3
| style="text-align:right" | -0.7
| style="text-align:right" | —
|-
| style="text-align:left" | ''Net income''
| style="text-align:right" | 7.9
| style="text-align:right" | 9.8
| style="text-align:right" | +26%
|}
</div>
Line 703 ⟶ 628:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earnings per share bridge, FY24 vsto FY25 <sup>p. 21</sup>
! style="text-align:left" | EUR
! class="col-s" style="text-align:right" | FY24Underlying earnings per share
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Underlying earnings per shareFY24
| style="text-align:right" | 3.59
| style="text-align:right" | 3.86
| style="text-align:right" | +8%
|-
| style="text-align:left" | From earningsEarnings growth
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | +6%
|-
| style="text-align:left" | From capitalCapital management
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | +3%
|-
| style="text-align:left" | From forexForex
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | -2%
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Shareholders' equity and ratios <sup>p. 22</sup>
! style="text-align:left" | —
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | HY25
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | SHETemporary (excl.earnings OCI)dilution from AXA IM sale
| style="text-align:right" | 58.0bn-1%
| style="text-align:right" | 52.7bn
| style="text-align:right" | 54.0bn
|-
| style="text-align:left" | Net OCIFY25
| style="text-align:right" | -83.1bn86
| style="text-align:right" | -7.2bn
| style="text-align:right" | -6.8bn
|-
| style="text-align:left" | SHE (excl. OCI & undated subordinated debt)
| style="text-align:right" | 53.2bn
| style="text-align:right" | 47.0bn
| style="text-align:right" | 49.4bn
|-
| style="text-align:left" | Debt gearing
| style="text-align:right" | 20.6%
| style="text-align:right" | 23.4%
| style="text-align:right" | 22.3%
|-
| style="text-align:left" | Underlying ROE
| style="text-align:right" | 15.2%
| style="text-align:right" | 17.5%
| style="text-align:right" | 16.0%
|}
</div>
 
* ''Underlying earnings'' drivers:
** Strong performance from insurance businesses <sup>p. 21</sup>
** Stable holding cost, expected to remain at current level in 2026 <sup>p. 21</sup>
* ''Net income'' drivers:
** Higher net income mainly reflecting higher underlying earnings and the gain from the sale of AXA IM <sup>p. 21</sup>
** Lower financial flows reflecting unfavorable forex impact <sup>p. 21</sup>
* Change is at constant FX for underlying earnings and net income; change is on a reported basis for underlying earnings per share <sup>p. 21</sup>
* (bar) ''Underlying earnings per share'' (In Euro): EUR 3.59 in FY24 to EUR 3.86 in FY25 (+8%) <sup>p. 21</sup>
 
=== Shareholders' equity ===
 
* (stacked bar) ''Shareholders' equity'' Group share:
** ''FY24'': EUR 49.9bn total (comprising SHE excl. OCI EUR 58.0bn and Net OCI EUR -8.1bn) <sup>p. 22</sup>
** ''HY25'': EUR 45.5bn total (comprising SHE excl. OCI EUR 52.7bn and Net OCI EUR -7.2bn) <sup>p. 22</sup>
** ''FY25'': EUR 47.2bn total (comprising SHE excl. OCI EUR 54.0bn and Net OCI EUR -6.8bn) <sup>p. 22</sup>
* ''SHE (excl. OCI & undated subordinated debt)'': EUR 53.2bn in FY24 → EUR 47.0bn in HY25 → EUR 49.4bn in FY25 <sup>p. 22</sup>
* ''Debt gearing'': 20.6% in FY24 → 23.4% in HY25 → 22.3% in FY25 <sup>p. 22</sup>
* ''Underlying ROE'': 15.2% in FY24 → 17.5% in HY25 → 16.0% in FY25 <sup>p. 22</sup>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Shareholders' equity walk, FY24 to FY25roll-forward <sup>p. 22</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24 to FY25
! class="col-s" style="text-align:right" | HY25 to FY25
|-
| style="text-align:left" | ''Opening Shareholders' equity''
| style="text-align:right" | 49.9
| style="text-align:right" | 45.5
Line 787 ⟶ 692:
| style="text-align:left" | Dividend
| style="text-align:right" | -4.6
| style="text-align:right" | -
|-
| style="text-align:left" | Annual share buyback
| style="text-align:right" | -1.2
| style="text-align:right" | -
|-
| style="text-align:left" | Anti-dilutive share buyback following the sale of AXA IM
Line 809 ⟶ 714:
| style="text-align:right" | 0.3
|-
| style="text-align:left" | ''Closing Shareholders' equity''
| style="text-align:right" | 47.2
| style="text-align:right" | 47.2
|}
</div>
 
* Including -1% from temporary earnings dilution from AXA IM sale due to timing of anti-dilutive share buyback <sup>p. 21</sup>
* Underlying earnings driven by strong performance from insurance businesses <sup>p. 21</sup>
* Holding cost stable, expected to remain at current level in 2026 <sup>p. 21</sup>
* Net income mainly reflecting higher underlying earnings and the gain from the sale of AXA IM <sup>p. 21</sup>
* Financial flows lower, reflecting unfavorable forex impact <sup>p. 21</sup>
 
== Higher organic cash remittance and robust cash position at Holding ==
 
=== Higher organic cash remittance and robust cash position at Holding ===
 
* (bar) ''Net cash remittance'' trend:
<div style="overflow-x:auto">
** ''FY24'': EUR 7.7bn total, comprising EUR 7.1bn ordinary remittance and EUR 0.6bn proceeds related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe <sup>p. 23</sup>
{| class="wikitable fintable"
|+** Net''FY25'': CashEUR Remittance,7.5bn FY24 vs FY25total <sup>p. 23</sup>
* ''Remittance ratio'' remained stable at 82% in FY24 and 82% in FY25, based on ordinary cash remittance of EUR 7.1bn in FY24 and EUR 7.5bn in FY25 <sup>p. 23</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Net Cash Remittance
| style="text-align:right" | 7.7
| style="text-align:right" | 7.5
|-
| style="text-align:left" | Ordinary cash remittance
| style="text-align:right" | 7.1
| style="text-align:right" | —
|-
| style="text-align:left" | Proceeds related to in-force treaties
| style="text-align:right" | 0.6
| style="text-align:right" | —
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ CashHolding cash position walk,bridge FY24 to FY25 in Euro billion <sup>p. 23</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Cash position
|-
| style="text-align:left" | ''FY24 Cash position''
| style="text-align:right" | 4.0
|-
Line 876 ⟶ 757:
| style="text-align:right" | +3.1
|-
| style="text-align:left" | ''FY25 Cash position''
| style="text-align:right" | 5.6
|}
</div>
 
* Remittance ratio¹: 82% (FY25) vs 82% (FY24) <sup>p. 23</sup>
* ¹Based on ordinary cash remittance of EUR 7.1bn in FY24 and EUR 7.5bn in FY25 <sup>p. 23</sup>.
* ²EUR 0.6bn proceeds related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe <sup>p. 23</sup>.
 
== Solvency II at 224% ==
 
=== Solvency II at 224% ===
Line 891 ⟶ 766:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ EligibleSolvency Own Funds (EOF)II walk, FY24 to FY25 <sup>p. 24</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | Eligible Own Funds (EOF)
! class="col-s" style="text-align:right" | SCR
! class="col-s" style="text-align:right" | Solvency II ratio (pts)
|-
| style="text-align:left" | FY24
| style="text-align:right" | 55.9
|-
| style="text-align:left" | Changes
| style="text-align:right" | +0.2
|-
| style="text-align:left" | —
| style="text-align:right" | +8.8
|-
| style="text-align:left" | —
| style="text-align:right" | -0.4
|-
| style="text-align:left" | —
| style="text-align:right" | -2.1
|-
| style="text-align:left" | —
| style="text-align:right" | -6.0
|-
| style="text-align:left" | —
| style="text-align:right" | -0.1
|-
| style="text-align:left" | FY25
| style="text-align:right" | 56.4
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Solvency Capital Requirement (SCR) walk, FY24 to FY25 <sup>p. 24</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Solvency Capital Requirement (SCR)
|-
| style="text-align:left" | FY24
| style="text-align:right" | 25.9
|-
| style="text-align:left" | Changes
| style="text-align:right" | 0.0
|-
| style="text-align:left" | —
| style="text-align:right" | +0.6
|-
| style="text-align:left" | —
| style="text-align:right" | 0.0
|-
| style="text-align:left" | —
| style="text-align:right" | -1.2
|-
| style="text-align:left" | —
| style="text-align:right" | 0.0
|-
| style="text-align:left" | —
| style="text-align:right" | -0.2
|-
| style="text-align:left" | FY25
| style="text-align:right" | 25.2
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Solvency II ratio walk, FY24 to FY25 <sup>p. 24</sup>
! style="text-align:left" | Solvency II ratio
! class="col-s" style="text-align:right" | Pts
|-
| style="text-align:left" | FY24
| style="text-align:right" | 216
|-
| style="text-align:left" | Regulatory & model changes
| style="text-align:right" | +0.2
| style="text-align:right" | 0.0
| style="text-align:right" | +0
|-
| style="text-align:left" | Normalized capital generation
| style="text-align:right" | +8.8
| style="text-align:right" | +0.6
| style="text-align:right" | +28
|-
| style="text-align:left" | Operating variance
| style="text-align:right" | -0.4
| style="text-align:right" | 0.0
| style="text-align:right" | -1
|-
| style="text-align:left" | Economic variance & FX
| style="text-align:right" | -2.1
| style="text-align:right" | -1.2
| style="text-align:right" | +4
|-
| style="text-align:left" | Dividend & annual share buyback
| style="text-align:right" | -6.0
| style="text-align:right" | 0.0
| style="text-align:right" | -24
|-
| style="text-align:left" | Management actions, debt & other
| style="text-align:right" | -0.1
| style="text-align:right" | -0.2
| style="text-align:right" | +2
|-
| style="text-align:left" | FY25
| style="text-align:right" | 56.4
| style="text-align:right" | 25.2
| style="text-align:right" | 224
|}
</div>
 
* Foreseeable dividends accounted for -EUR 4.8bn.
* Provision for annual share buyback for 2026 accounted for -EUR 1.25bn.
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Key sensitivities onof Solvency II Ratioratio as of December 31, 2025 (base 224%) <sup>p. 24</sup>
! style="text-align:left" | Sensitivity
! class="col-s" style="text-align:right" | PtsImpact (pts)
|-
| style="text-align:left" | Interest rate +50bps
Line 1,006 ⟶ 838:
| style="text-align:right" | -4
|-
| style="text-align:left" | Listed Equity (excl.excluding PE & Infra) +25%
| style="text-align:right" | -1
|-
| style="text-align:left" | Listed Equity (excl.excluding PE & Infra) -25%
| style="text-align:right" | +2
|-
Line 1,022 ⟶ 854:
|}
</div>
 
* ¹Sensitivity to Euro sovereign spreads assumes a 50bps spread widening of the Euro sovereign bonds vs. the Euro swap curve (applied on sovereign and quasi-sovereign exposures) <sup>p. 24</sup>.
* Euro sovereign spreads sensitivity assumes a 50bps spread widening of the Euro sovereign bonds vs. the Euro swap curve, applied on sovereign and quasi-sovereign exposures.
* ²Sensitivity to credit rating migration assumes 20% of corporate bonds (including private debt) held are downgraded by one full letter (3 notches) <sup>p. 24</sup>.
* Credit rating migration sensitivity assumes 20% of corporate bonds (including private debt) held are downgraded by one full letter (3 notches).
* Changes: +EUR 0.2bn, +EUR 8.8bn, -EUR 0.4bn, -EUR 2.1bn, -EUR 6.0bn (Foreseeable dividends: EUR 4.8bn; Provision for annual Share buyback for 2026: EUR -1.25bn), -EUR 0.1bn <sup>p. 24</sup>
 
=== Solvency II -impact of the end of grandfathering period and Solvency II revision ===
 
<div style="overflow-x:auto">
* '''Ratio as of 31/12/2025''': 224% <sup>p. 25</sup>
{| class="wikitable fintable"
* '''Impact of the end of grandfathering period on January 1, 2026''': -10pts to 215% <sup>p. 25</sup>
**|+ EURSolvency 2.4bnII grandfatheredratio debt no longer eligible as capital from January 1, 2026impacts <sup>p. 25</sup>
! style="text-align:left" | Event
* '''Impact of Solvency II revision to come into effect in 1Q27''': +17pts¹ <sup>p. 25</sup>
! class="col-s" style="text-align:right" | Impact (pts)
** No change expected in organic capital generation <sup>p. 25</sup>
|-
** Additional capital flexibility <sup>p. 25</sup>
| style="text-align:left" | Solvency II ratio as of December 31, 2025
* ¹Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date <sup>p. 25</sup>.
| style="text-align:right" | 224
|-
| style="text-align:left" | Grandfathering end impact on January 1, 2026
| style="text-align:right" | -10
|-
| style="text-align:left" | Solvency II revision impact to come into effect in 1Q27
| style="text-align:right" | +17
|}
</div>
 
* EUR 2.4bn grandfathered debt is no longer eligible as capital from January 1, 2026.
== Thomas Buberl, Group CEO conclusion ==
* No change is expected in organic capital generation.
* Provides additional capital flexibility.
* Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date.
* ''Grandfathering end impact'' on January 1, 2026 is -10pts to 215% <sup>p. 25</sup>.
 
=== Thomas Buberl, Group CEO conclusion ===
 
* Conclusion''Section divider'' for the conclusion presentation by Thomas Buberl, Group CEO <sup>p. 26</sup>.
 
== Conclusion ==
 
=== Conclusion ===
 
* '''Record results''', achieved at the top end of the target range while enhancing reserve prudence <sup>p. 27</sup>.
* ''All businesses'' in excellent shape, delivering strong growth and profitability <sup>p. 27</sup>.
* '''Diversified franchise''', well-positioned to capture future growth opportunities <sup>p. 27</sup>.
* ''Laying foundations'' for the next plan and confident in delivering sustainable earnings growth <sup>p. 27</sup>.
 
== Q&A Full Year 2025 earnings ==
 
=== February 26, 2026 Q&A Full Year 2025 earnings ===
 
* ''Q&A session'' for the Full Year 2025 Earnings presentation held on February 26, 2026 <sup>p. 28</sup>.
* Date: February 26, 2026 <sup>p. 28</sup>
 
=== AXA Investor Relations | Keep in touch ===
 
* '''MeetInvestor ourRelations management'contact'': +33 1 40 75 48 42; investor.relations@axa.com <sup>p. 29</sup>
** March''Follow us'': Roadshows in Europe and USwww.axa.com <sup>p. 29</sup>
 
** May 5: 1Q25 Activity Indicators in Paris <sup>p. 29</sup>
<div style="overflow-x:auto">
** June 2: BNP Paribas Exane CEO Conference in Paris <sup>p. 29</sup>
{| class="wikitable"
** June 2-4: Goldman Sachs European Financials Conference in Zurich <sup>p. 29</sup>
**|+ JulyMeet 31:our HY26management Earningsevent Release in Parisschedule <sup>p. 29</sup>
! style="text-align:left" | Date
** September 21: AXA Investor Day in London <sup>p. 29</sup>
! class="col-m" style="text-align:right" | Event
* '''Contact us''' <sup>p. 29</sup>
! class="col-m" style="text-align:right" | Location
** Investor Relations: +33 1 40 75 48 42 <sup>p. 29</sup>
|-
** Email: investor.relations@axa.com <sup>p. 29</sup>
| style="text-align:left" | March
* '''Follow us''' <sup>p. 29</sup>
| class="col-m" style="text-align:right" | Roadshows
** Website: www.axa.com <sup>p. 29</sup>
| class="col-m" style="text-align:right" | Europe and US
** Social media icons for YouTube, Facebook, Instagram, Twitter, LinkedIn, and a leaf icon <sup>p. 29</sup>
|-
| style="text-align:left" | May 5
| class="col-m" style="text-align:right" | 1Q25 Activity Indicators
| class="col-m" style="text-align:right" | Paris
|-
| style="text-align:left" | June 2
| class="col-m" style="text-align:right" | BNP Paribas Exane CEO Conference
| class="col-m" style="text-align:right" | Paris
|-
| style="text-align:left" | June 2-4
| class="col-m" style="text-align:right" | Goldman Sachs European Financials Conference
| class="col-m" style="text-align:right" | Zurich
|-
| style="text-align:left" | July 31
| class="col-m" style="text-align:right" | HY26 Earnings Release
| class="col-m" style="text-align:right" | Paris
|-
| style="text-align:left" | September 21
| class="col-m" style="text-align:right" | AXA Investor Day
| class="col-m" style="text-align:right" | London
|}
</div>
 
== Appendices ==
 
===* Section divider for ''Appendices'' <sup>p. ===30</sup>
 
=== Table of contents ===
* Appendices <sup>p. 30</sup>
 
* '''Debt and Invested Assets''' <sup>p. 31</sup>
* ''Additional P&C disclosures'' <sup>p. 36</sup>
* ''Additional IFRS17 disclosures'' <sup>p. 41</sup>
* ''Sustainability'' <sup>p. 44</sup>
 
=== Gross financial debt and maturity breakdown as of December 31st, 2025 ===
Line 1,089 ⟶ 951:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Gross financial debt by type, FY24-Jan 2026 <sup>p. 32</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
Line 1,096 ⟶ 958:
|-
| style="text-align:left" | Tier 1
| style="text-align:right" | 34.58
| style="text-align:right" | 34.56
| style="text-align:right" | 53.82
|-
| style="text-align:left" | Tier 2
Line 1,106 ⟶ 968:
|-
| style="text-align:left" | Senior debt
| style="text-align:right" | 43.85
| style="text-align:right" | 43.65
| style="text-align:right" | 35.28
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | 19.2
| style="text-align:right; font-weight:bold" | 22.3
| style="text-align:right; font-weight:bold" | 20.3
| style="text-align:right; font-weight:bold" | 20.3
|-
| style="text-align:left" | Debt gearing
| style="text-align:right" | 20.6%
| style="text-align:right" | 22.3%
| style="text-align:right" | —
|}
</div>
Line 1,119 ⟶ 986:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Contractual maturity breakdown of debt by type <sup>p. 32</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Tier 1
! class="col-s" style="text-align:right" | Tier 2
! class="col-s" style="text-align:right" | Senior debt
! class="col-s" style="text-align:right" | Tier 2
! class="col-s" style="text-align:right" | Tier 1
|-
| style="text-align:left" | 2025
| style="text-align:right" | 0.5
| style="text-align:right" | 0.5
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2026
| style="text-align:right" | 0.9
| style="text-align:right" | 0.9
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2027
| style="text-align:right" | 0.5
| style="text-align:right" | 0.5
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2028
| style="text-align:right" | 0.9
| style="text-align:right" | 0.9
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2029
| style="text-align:right" | 0.9
| style="text-align:right" | 0.9
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | 0.9
| style="text-align:right" | 0.9
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2031-2039
| style="text-align:right" | 0.9
| style="text-align:right" | 0.9
| style="text-align:right" | 01.5
|-
| style="text-align:left" | ≥2040
| style="text-align:right" | —
| style="text-align:right" | 10.8
| style="text-align:right" | 0.25
| style="text-align:right" | 1.4
|-
| style="text-align:left" | Undated
| style="text-align:right" | 4.6
| style="text-align:right" | 0.7
| style="text-align:right" | 0.5
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Grandfathered debt by contractual maturity <sup>p. 32</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Tier 1
! class="col-s" style="text-align:right" | Tier 2
|-
| style="text-align:left" | 2031-2039Grandfathered debt (contractual)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 Undated
| style="text-align:right" | 1.4
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | 0.2
|-
| style="text-align:left" | Tier 2 ≥2040
| style="text-align:right" | —
| style="text-align:right" | 0.2
| style="text-align:right" | —
|-
| style="text-align:left" | Undated
| style="text-align:right" | 0.5
| style="text-align:right" | —
|}
Line 1,195 ⟶ 1,041:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Economic maturity breakdown of debt by type <sup>p. 32</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Tier 1
! class="col-s" style="text-align:right" | Tier 2
! class="col-s" style="text-align:right" | Senior debt
! class="col-s" style="text-align:right" | Tier 2
! class="col-s" style="text-align:right" | Tier 1
|-
| style="text-align:left" | 2025
| style="text-align:right" | 0.1
| style="text-align:right" | 0.1
| style="text-align:right" | 0.1
|-
| style="text-align:left" | 2026
| style="text-align:right" | 0.1
| style="text-align:right" | 0.1
| style="text-align:right" | 0.1
|-
| style="text-align:left" | 2027
| style="text-align:right" | —
| style="text-align:right" | 2.4
| style="text-align:right" | 0.1
| style="text-align:right" | 0.1
|-
| style="text-align:left" | 2028
| style="text-align:right" | 2.0
| style="text-align:right" | 0.1
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2029
| style="text-align:right" | 0.9
| style="text-align:right" | 02.10
| style="text-align:right" | 0.1
|-
| style="text-align:left" | 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | 0.19
| style="text-align:right" | 0.1
|-
| style="text-align:left" | 2031-2039
| style="text-align:right" | 0.4
| style="text-align:right" | 6.4
| style="text-align:right" | 0.2
| style="text-align:right" | 1.5
|-
| style="text-align:left" | ≥2040
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.5
| style="text-align:right" | 0.1
| style="text-align:right" | 0.7
|-
| style="text-align:left" | Undated
| style="text-align:right" | 4.0
| style="text-align:right" | 0.1
| style="text-align:right" | 0.7
| style="text-align:right" | —
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Grandfathered debt by economic maturity <sup>p. 32</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Tier 1
! class="col-s" style="text-align:right" | Tier 2
|-
| style="text-align:left" | 2031-2039Grandfathered debt (economic)
| style="text-align:right" | 0.7
| style="text-align:right" | 0.2
| style="text-align:right" | —
|-
| style="text-align:left" | ≥2040Tier 1 2026
| style="text-align:right" | 0.21
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | UndatedTier 1 2028
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 2031-2039
| style="text-align:right" | 0.4
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 Undated
| style="text-align:right" | 0.8
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 ≥2040
| style="text-align:right" | —
| style="text-align:right" | 0.2
| style="text-align:right" | —
|}
</div>
 
* In January 2026, AXA called the remaining Tier 2 grandfathered GBP 139m due 2054 callable 2034 (5.625% issued January 2014) and the Tier 1 grandfathered EUR 250m perpetual callable 2010 floating (issued January 2005).
* Debt gearing: 20.6% for FY24; 22.3% for FY25 <sup>p. 32</sup>
* Economic maturity accounts for the first date of step-up calls on institutionally placed subordinated debt.
* Nominal debt <sup>p. 32</sup>
* For Solvency II RT1 debt with no step-up, the undated nature of the instrument is retained for economic maturity.
* In January 2026, AXA has called (i) the remaining T2 GF GBP 139m due 2054 callable 2034 5.625% issued January 2014 and (ii) the T1 GF EUR 250m perpetual callable 2010 floating issued January 2005 <sup>p. 32</sup>
 
* Economic maturity takes into account the first date of step up calls on institutionally placed subordinated debt <sup>p. 32</sup>
=== General account invested assets ===
* For Solvency 2 RT1 debt, which has no step-up, the undated nature of the instrument is retained for the purpose of this diagram <sup>p. 32</sup>
* This should not be construed, nor relied upon, as an indication that the instrument will not be called for redemption when callable <sup>p. 32</sup>
* Such decision will depend on several factors, including capital and liquidity position and refinancing economics at the prevailing time <sup>p. 32</sup>
* '''Jan 1st 2026''' (End of the grandfathering period): Total EUR 20.3bn; Tier 1 EUR 5.8bn (o/w EUR 0.4bn redeemed in Jan 2026), Tier 2 EUR 11.3bn, Senior debt EUR 3.2bn <sup>p. 32</sup>
 
===* ''Total General Account'' invested assets ===at EUR 450bn <sup>p. 33</sup>.
* ''Duration gap'' at -0.4 year <sup>p. 33</sup>.
* (donut) ''FY25 General Account invested assets'': EUR 450bn total; mix includes Fixed income, Real estate, Infrastructure equity, Listed equities, Private equity and hedge funds, Cash, and Policy loans <sup>p. 33</sup>.
* ''Other fixed income'' includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn), and Agency Pools (EUR 8bn) <sup>p. 33</sup>.
* ''Listed equities'' includes hedges; listed equities excluding hedges at EUR 14bn <sup>p. 33</sup>.
* ''Private equity and hedge funds'' includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn), and Non-listed Equities (EUR 1bn) <sup>p. 33</sup>.
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 Total General Account investedInvested assets breakdown FY25 <sup>p. 33</sup>
! style="text-align:left" | AssetEUR classbillion unless otherwise mentioned
! class="col-s" style="text-align:right" | ShareFY25
! class="col-s" style="text-align:right" | EUR billion%
|-
| style="text-align:left" | ''Fixed income''
| style="text-align:right" | 77%
| style="text-align:right" | 345
| style="text-align:right" | 77%
|-
| style="text-align:left" | Real''o/w estateGovernment bonds''
| style="text-align:right" | 9%167
| style="text-align:right" | 37%
|-
| style="text-align:left" | ''o/w Corporate bonds and loans''
| style="text-align:right" | 121
| style="text-align:right" | 27%
|-
| style="text-align:left" | ''o/w Other fixed income''
| style="text-align:right" | 56
| style="text-align:right" | 13%
|-
| style="text-align:left" | ''Real estate''
| style="text-align:right" | 41
| style="text-align:right" | 9%
|-
| style="text-align:left" | ''Infrastructure equity''
| style="text-align:right" | 2%
| style="text-align:right" | 10
|-
| style="text-align:left" | Listed equities
| style="text-align:right" | 2%
|-
| style="text-align:left" | ''Listed equities''
| style="text-align:right" | 10
| style="text-align:right" | 2%
|-
| style="text-align:left" | ''Private equity and hedge funds''
| style="text-align:right" | 5%
| style="text-align:right" | 23
| style="text-align:right" | 5%
|-
| style="text-align:left" | ''Cash''
| style="text-align:right" | 4%
| style="text-align:right" | 19
| style="text-align:right" | 4%
|-
| style="text-align:left" | ''Policy loans''
| style="text-align:right" | 0%
| style="text-align:right" | 2
| style="text-align:right" | 0%
|-
| style="text-align:left" | '''Total Insurance Invested Assets'''
| style="text-align:right" | '''100%'''450
| style="text-align:right" | '''450'''100%
|}
</div>
 
=== Structured and private credit assets ===
* '''Fixed income''' o/w:
** '''Government bonds''': EUR 167bn (37%) <sup>p. 33</sup>
** '''Corporate bonds and loans''': EUR 121bn (27%) <sup>p. 33</sup>
** '''Other fixed income'''¹: EUR 56bn (13%) <sup>p. 33</sup>
* '''Duration gap''': -0.4 year <sup>p. 33</sup>
* ¹ '''Other fixed income''' includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn) and Agency Pools (EUR 8bn) <sup>p. 33</sup>
* ² '''Listed equities''' includes hedges; Listed equities excluding hedges at EUR 14bn <sup>p. 33</sup>
* ³ '''Private equity and hedge funds''' includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn) and Non-listed Equities (EUR 1bn) <sup>p. 33</sup>
* ⁴ Please refer to the financial supplement for more details <sup>p. 33</sup>
 
* ''Total structured and private credit assets'' stood at EUR 69bn, representing 15% of the total General Account portfolio, with 54% participating <sup>p. 34</sup>.
=== Structured and Private Credit assets ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25Structured Generaland Accountprivate investedcredit assets inbreakdown structured and private creditFY25 <sup>p. 34</sup>
! style="text-align:left" | AssetInvested classassets (100%) in EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | EUR billionFY25
! class="col-s" style="text-align:right" | % of total G/A¹ portfolio
! class="col-m" style="text-align:right" | Comments
|-
| style="text-align:left" | Residential Mortgages
| style="text-align:right" | 16
| style="text-align:right" | 4%
| style="text-align:right" | - EUR 6bn Dutch mortgages, NHG guaranteed - EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV)
|-
| style="text-align:left" | CLO & ABS
| style="text-align:right" | 25
| style="text-align:right" | 6%
| style="text-align:right" | - 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA)
|-
| style="text-align:left" | Infrastructure debt
| style="text-align:right" | 8
| style="text-align:right" | 2%
| style="text-align:right" | - Skewed towards resilient industries (Telecom, Utilities, Transport)
|-
| style="text-align:left" | CRE debt
| style="text-align:right" | 8
| style="text-align:right" | 2%
| style="text-align:right" | - Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV
|-
| style="text-align:left" | Mid-Market lending
| style="text-align:right" | 10
| style="text-align:right" | 2%
| style="text-align:right" | - Strong diversification with EUR 8m average ticket - Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation
|-
| style="text-align:left" | Other
| style="text-align:right" | 2
| style="text-align:right" | 0%
| style="text-align:right" | —
|-
| style="text-align:left" | '''Total Structured and Private Credit Assets'''
| style="text-align:right" | '''69'''
| style="text-align:right" | '''15%'''
| style="text-align:right" | o/w 54% participating
|}
</div>
 
* ''General Account'' (G/A) represents the investment portfolio <sup>p. 34</sup>.
* '''Residential Mortgages''':
** EUR 6bn Dutch mortgages, NHG guaranteed <sup>p. 34</sup>
** EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV) <sup>p. 34</sup>
* '''CLO & ABS''':
** 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA) <sup>p. 34</sup>
* '''Infrastructure debt''':
** Skewed towards resilient industries (Telecom, Utilities, Transport) <sup>p. 34</sup>
* '''CRE debt''':
** Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV <sup>p. 34</sup>
* '''Mid-Market lending''':
** Strong diversification with EUR 8m average ticket <sup>p. 34</sup>
** Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation <sup>p. 34</sup>
* '''Total Structured and Private Credit Assets''':
** o/w 54% participating <sup>p. 34</sup>
* G/A: General Account <sup>p. 34</sup>
 
=== Investment portfolio | Fixed Incomeincome reinvestment ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 Fixed Income Reinvestment breakdownasset mix <sup>p. 35</sup>
! style="text-align:left" | CategoryAsset mix
! class="col-s" style="text-align:right" | Share
! class="col-s" style="text-align:right" | Average rating
|-
| style="text-align:left" | Government bonds & related
| style="text-align:right" | 32%
| style="text-align:right" | AA
|-
| style="text-align:left" | Investment grade credit
| style="text-align:right" | 40%
| style="text-align:right" | A
|-
| style="text-align:left" | ABS/CLO/IG fund financing
| style="text-align:right" | 21%
| style="text-align:right" | —
|-
| style="text-align:left" | Below investment grade credit
| style="text-align:right" | 7%
| style="text-align:right" | —
|}
</div>
Line 1,416 ⟶ 1,266:
{| class="wikitable fintable"
|+ FY25 Fixed Income Reinvestment Yield <sup>p. 35</sup>
! style="text-align:left" | CategoryFixed Income Type
! class="col-s" style="text-align:right" | Yield
|-
Line 1,430 ⟶ 1,280:
</div>
 
* '''EuroFixed 57income billionreinvestment fixedtotaled incomeEUR invested57bn atin 3.9%'''FY25 <sup>p. 35</sup>
* Reinvestment yield achieved at 3.9% on EUR 57bn fixed income <sup>p. 35</sup>
** Average duration of 9 years <sup>p. 35</sup>
** Includes EUR 19.7bn of Private & Structured Credit investedreinvestment of EUR 19.7bn at 4.7% (yield, including CLOs, ABS, Infra & CRE debt, Fund financing, and Private HY) <sup>p. 35</sup>
** GradualStrategic shift characterized by a gradual transition from alternative total return assets to Private & Structured credit <sup>p. 35</sup>
 
* ¹ '''Government bonds & related''' refers to Government and Corporate bonds and related <sup>p. 35</sup>
=== Table of contents ===
* ² '''Private & Structured fixed income''' refers to Private & Structured credit (CLOs, ABS, Infra & CRE debt, Fund financing and Private hybrid) <sup>p. 35</sup>
 
* ''Debt and Invested Assets'' on page 31 <sup>p. 36</sup>
* '''Table of contents''':
** 1.''Additional DebtP&C anddisclosures'' Investedon Assets,page p.3136 <sup>p. 36</sup>
** 2. ''Additional P&CIFRS17 disclosures,'' on page p.3641 <sup>p. 36</sup>
** 3.''Sustainability'' Additionalon IFRS17page disclosures, p.4144 <sup>p. 36</sup>
** 4. Sustainability, p.44 <sup>p. 36</sup>
 
=== AXA XL Insurance | Large Commercial & Specialty business ===
Line 1,447 ⟶ 1,297:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 GWP by line of business, USD 19bn total <sup>p. 37</sup>
! style="text-align:left" | Line of business
! class="col-s" style="text-align:right" | Share
Line 1,460 ⟶ 1,310:
| style="text-align:right" | 19%
|-
| style="text-align:left" | Professional lines (including Cyber)
| style="text-align:right" | 17%
|}
Line 1,467 ⟶ 1,317:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 GWP by geography, USD 19bn total <sup>p. 37</sup>
! style="text-align:left" | Geography
! class="col-s" style="text-align:right" | Share
Line 1,482 ⟶ 1,332:
</div>
 
<div style="overflow-x:auto">
* Well diversified across lines of business and geographies <sup>p. 37</sup>
{| class="wikitable"
* Leading market positions across lines <sup>p. 37</sup>
**|+ TopProfitability 3vs globallyEx-price growth (%) <sup>p. 37</sup>
! style="text-align:left" | Line of business
*** Multinational Programs (Source: McKinsey) <sup>p. 37</sup>
! class="col-m" style="text-align:right" | Profitability
*** Marine (Source: Aon, Guy Carpenter, and Global Market Insights) <sup>p. 37</sup>
! class="col-m" style="text-align:right" | Ex-price growth
*** Fine Art & Specie (Source: Industry Research Biz (January 2026)) <sup>p. 37</sup>
|-
* Managing the cycle to deliver consistent profitability <sup>p. 37</sup>
| style="text-align:left" | Property
** (scatter plot) '''Profitability vs. Ex-price growth''':
| class="col-m" style="text-align:right" | high
*** Property (top right) <sup>p. 37</sup>
| class="col-m" style="text-align:right" | high
*** Specialty (middle right) <sup>p. 37</sup>
|-
*** Casualty (middle left) <sup>p. 37</sup>
| style="text-align:left" | Specialty
*** Professional lines (bottom left) <sup>p. 37</sup>
| class="col-m" style="text-align:right" | medium-high
| class="col-m" style="text-align:right" | medium-high
|-
| style="text-align:left" | Casualty
| class="col-m" style="text-align:right" | medium
| class="col-m" style="text-align:right" | medium
|-
| style="text-align:left" | Professional lines
| class="col-m" style="text-align:right" | lower
| class="col-m" style="text-align:right" | lower
|}
</div>
 
* Business diversification is well balanced across lines of business and geographies <sup>p. 37</sup>
=== P&C | Focus on Reserves ===
* Market leadership positions AXA XL in the top 3 globally for <sup>p. 37</sup>:
** Multinational Programs <sup>p. 37</sup>
** Marine <sup>p. 37</sup>
** Fine Art & Specie <sup>p. 37</sup>
* Cycle management is utilized to deliver consistent profitability <sup>p. 37</sup>
* ''Property'': high profitability, high ex-price growth <sup>p. 37</sup>
* ''Specialty'': medium-high profitability, medium-high ex-price growth <sup>p. 37</sup>
* ''Casualty'': medium profitability, medium ex-price growth <sup>p. 37</sup>
* ''Professional lines'': lower profitability, lower ex-price growth <sup>p. 37</sup>
 
=== P&C | Focus on reserves ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Claims reservesand ratio (Net undiscounted claimstechnical reserves/Net earned premiums)ratios <sup>p. 38</sup>
! style="text-align:left" | %
! class="col-s" style="text-align:right" | FY18
Line 1,510 ⟶ 1,383:
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Claims reserves ratio (IFRS4 basis)
| style="text-align:right" | 179
| style="text-align:right" | 185
Line 1,520 ⟶ 1,393:
| style="text-align:right" | —
|-
| style="text-align:left" | Claims reserves ratio (IFRS17 basis)
| style="text-align:right" | —
| style="text-align:right" | —
Line 1,529 ⟶ 1,402:
| style="text-align:right" | 180
| style="text-align:right" | 175
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Technical reserves ratio (Net undiscounted technical reserves /Net earned premiums) <sup>p. 38</sup>
! style="text-align:left" | %
! class="col-s" style="text-align:right" | FY18
! class="col-s" style="text-align:right" | FY19
! class="col-s" style="text-align:right" | FY20
! class="col-s" style="text-align:right" | FY21
! class="col-s" style="text-align:right" | FY22
! class="col-s" style="text-align:right" | FY23
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Technical reserves ratio (IFRS4 basis)
| style="text-align:right" | 213
| style="text-align:right" | 227
Line 1,555 ⟶ 1,413:
| style="text-align:right" | —
|-
| style="text-align:left" | Technical reserves ratio (IFRS17 basis)
| style="text-align:right" | —
| style="text-align:right" | —
Line 1,566 ⟶ 1,424:
|}
</div>
* Technical reserves definition includes net undiscounted claims reserves and unearned premium reserves <sup>p. 38</sup>.
 
=== P&C | 2026 Simplified Group Nat Cat reinsurance program 1 ===
* Technical reserves include net undiscounted claims reserves and unearned premium reserves <sup>p. 38</sup>
 
=== P&C | 2026 Simplified Group Nat Cat Reinsurance Program 1 ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Insurance segment (occurrence protection) capacity and retention <sup>p. 39</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Capacity
! class="col-s" style="text-align:right" | Retention
! class="col-m" style="text-align:right" | Capacity
|-
| style="text-align:left" | EU Windstorm
| style="text-align:right" | 4.0600m
| style="text-align:right" | 04.60bn
|-
| style="text-align:left" | Europe Flood
| style="text-align:right" | 2.1450m
| style="text-align:right" | 02.451bn
|-
| style="text-align:left" | Europe Earthquake
| style="text-align:right" | 2.1400m
| style="text-align:right" | 02.41bn
|-
| style="text-align:left" | NA Hurricane
| style="text-align:right" | 1.2600m
| style="text-align:right" | 01.62bn
|-
| style="text-align:left" | NA Earthquake
| style="text-align:right" | 1.2600m
| style="text-align:right" | 01.62bn
|-
| style="text-align:left" | Per other perils
| style="text-align:right" | 0.8400m
| style="text-align:right" | 0.4Varies by peril type
|}
</div>
* Stable retentionRetention levels maintainedremained stable in 2026 ascompared into 2025 <sup>p. 39</sup>.
* (diagram) '''Reinsurance segment'' (illustrative)''': Alternative Capital & Cat Bonds <sup>p. 39</sup>
* ExcludesCovered localvia reinsurance''Alternative coversCapital & Cat Bonds'' <sup>p. 39</sup>
* Varying retention between MX and NA (EUR 400m MX, EUR 600m NA) <sup>p. 39</sup>
* Other perils include Turkey earthquake, Other Europe and NA perils, South America Earthquake as well as a series of other secondary perils <sup>p. 39</sup>
* Capacity varies by peril type <sup>p. 39</sup>
* '''Europe Flood''': Capacity EUR 2.1bn, Retention EUR 450m <sup>p. 39</sup>
 
=== P&C | AXA Group earnings deviation with different levels of Nat Cat cost 1 in 2026 ===
Line 1,616 ⟶ 1,469:
{| class="wikitable fintable"
|+ Group underlying earnings deviation to average Nat Cat charges in 2026 <sup>p. 40</sup>
! style="text-align:left" | PercentileReturn period / probability percentile
! class="col-s" style="text-align:right" | Deviation (EUR billion)
|-
| style="text-align:left" | 95th (1/20y (95th percentile)
| style="text-align:right" | -1.2
|-
| style="text-align:left" | 90th (1/10y (90th percentile)
| style="text-align:right" | -0.8
|-
| style="text-align:left" | 80th (1/5y (80th percentile)
| style="text-align:right" | -0.4
|-
| style="text-align:left" | 50thMedian (Median50th percentile)
| style="text-align:right" | +0.1
|-
| style="text-align:left" | 20th (1/5y (20th percentile)
| style="text-align:right" | +0.5
|-
| style="text-align:left" | 10th (1/10y (10th percentile)
| style="text-align:right" | +0.7
|-
| style="text-align:left" | 5th (1/20y (5th percentile)
| style="text-align:right" | +0.8
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Average Expectedexpected Nat Cat charges net of reinsurance, pre-tax <sup>p. 40</sup>
! style="text-align:left" | EUR billionYear
! class="col-s" style="text-align:right" | 2025EUR billion
! class="col-s" style="text-align:right" | 2026Estimated impact on GEP
|-
| style="text-align:left" | Average Expected Nat Cat charges2025
| class="col-s" style="text-align:right" | 2.6
| class="col-s" style="text-align:right" | 2ca. 4.75%
|-
| style="text-align:left" | 2026
| class="col-s" style="text-align:right" | 2.7
| class="col-s" style="text-align:right" | ca. 4.5%
|}
</div>
* '''More severe years'' result in -a Negativenegative deviation in ca. 40% of cases''' <sup>p. 40</sup>.
* '''Less severe years'' result in -a Positivepositive deviation in ca. 60% of cases''' <sup>p. 40</sup>.
* Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance. Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance). <sup>p. 40</sup>
* Estimated impact on GEP ca. 4.5% for 2025 <sup>p. 40</sup>
 
* Estimated impact on GEP ca. 4.5% for 2026 <sup>p. 40</sup>
=== Table of contents ===
* Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance <sup>p. 40</sup>
* Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance) <sup>p. 40</sup>
* '''Average Expected Nat Cat charges''' net of reinsurance, pre-tax (in Euro billion) <sup>p. 40</sup>
 
* 1. ''Debt and Invested Assets'' <sup>p. 31</sup>
* 2. ''Additional P&C disclosures'' <sup>p. 36</sup>
* 3. ''Additional IFRS17 disclosures'' <sup>p. 41</sup>
* 4. ''Sustainability'' <sup>p. 44</sup>
 
=== P&C | Margin analysis ===
Line 1,671 ⟶ 1,526:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Technical Result (P&C) margin analysis and underlying earnings FY25 <sup>p. 42</sup>
! style="text-align:left" | EUR million
! class="col-s" style="text-align:right" | ValueFY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | ''Current Accident Year Undiscounted Technical Margin''
| style="text-align:right" | 2,778
| style="text-align:right" | +707
|-
| style="text-align:left" | ''Current Accident Year Discounting''
| style="text-align:right" | 2,009
| style="text-align:right" | +115
|-
| style="text-align:left" | ''Prior Years' Reserve Development (PYD)''
| style="text-align:right" | 622
| style="text-align:right" | -341
|}
</div>
 
* Gross Earned Premiums: EUR 57,656 (+6%)
* Current Accident Year Undiscounted Combined Ratio: 95.2% (-1.0pt)
* o/w Nat Cats: 3.4% (-0.4pt)
* Discounting Ratio (in Combined Ratio points): -3.5% (+0.0pt)
* Current Accident Year Net Claims reserves: EUR 19.0bn
* Duration: 4.0 years
* Current Accident Year Discount Rate: 2.8%
* PYD ratio: -1.1% (+0.7pt)
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Sensitivity to Current Accident Year discount rate changes <sup>p. 42</sup>
! style="text-align:left" | Change in discount rate
! class="col-s" style="text-align:right" | Impact (EUR billion)
|-
| style="text-align:left" | +25bps''Investment Income''
| style="text-align:right" | +0.2
|-
| style="text-align:left" | -25bps
| style="text-align:right" | -0.2
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Financial Result (P&C) <sup>p. 42</sup>
! style="text-align:left" | EUR million
! class="col-s" style="text-align:right" | Value
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Investment Income
| style="text-align:right" | 3,988
| style="text-align:right" | +435
|-
| style="text-align:left" | ''Insurance Finance Expenses''
| style="text-align:right" | -1,358
| style="text-align:right" | -235
|}
</div>
 
* FY25 Average Assets: EUR 115bn
* Asset book yield: 3.5%
* FY25 Reinvestment yield¹: 4.3%
* FY24 Reserves at locked-in rate: EUR 71bn
* Liability book yield: 1.9%
* 2025 Insurance Finance Expenses (pre-tax): ~EUR -1.4bn
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Sensitivity of 2025e Insurance Finance Expenses to changes in 2025 current AY Discount <sup>p. 42</sup>
! style="text-align:left" | Change in discount rate
! class="col-s" style="text-align:right" | Impact (EUR million)
|-
| style="text-align:left" | +25bps''Underlying Earnings before tax''
| style="text-align:right" | -50
|-
| style="text-align:left" | -25bps
| style="text-align:right" | +50
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying Earnings (P&C) <sup>p. 42</sup>
! style="text-align:left" | EUR million
! class="col-s" style="text-align:right" | Value
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Underlying Earnings before tax
| style="text-align:right" | 8,040
| style="text-align:right" | +681
Line 1,770 ⟶ 1,563:
| style="text-align:right" | -10
|-
| style="text-align:left" | ''Underlying Earnings''
| style="text-align:right" | 5,872
| style="text-align:right" | +501
Line 1,776 ⟶ 1,569:
</div>
 
* ''Gross earned premiums'' EUR 57,656m (+6%) <sup>p. 42</sup>
* Growth vs. FY24 (at constant FX): +9%
* (flow) '''TechnicalUndiscounted Result'combined ratio'' 95.2% (in-1.0pt); EURof million,which preNat Cats was 3.4% (-tax0.4pt) <sup>p. 42</sup>
* (flow) '''FinancialDiscounting Result'ratio'' -3.5% (+0.0pt in EURCombined million,Ratio pre-taxpoints) <sup>p. 42</sup>
* ''Net claims reserves'' for current accident year at EUR 19.0bn; duration of 4.0 years; discount rate of 2.8% <sup>p. 42</sup>
* ''PYD ratio'' -1.1% (+0.7pt) <sup>p. 42</sup>
* ''Average assets'' for FY25 at EUR 115bn; asset book yield at 3.5%; reinvestment yield on fixed income assets at 4.3% <sup>p. 42</sup>
* ''Reserves at locked-in rate'' for FY24 at EUR 71bn; liability book yield at 1.9% <sup>p. 42</sup>
* ''Underlying earnings growth'' +9% vs. FY24 at constant FX <sup>p. 42</sup>
* ''Discount rate sensitivity'': FY25 sensitivity to current accident year discount rate changes (parallel shift of the full-year average yield curve):
** +25bps: +EUR 0.2bn <sup>p. 42</sup>
** -25bps: -EUR 0.2bn <sup>p. 42</sup>
* ''Insurance finance expenses'': 2026e pre-tax expected at ~EUR -1.4bn <sup>p. 42</sup>
** Sensitivity of 2026e expenses to changes in 2025 current AY discount: +25bps ~EUR -50m; -25bps ~EUR +50m <sup>p. 42</sup>
 
=== L&H | Margin analysis ===
 
* Includes''L&H margin analysis'' includes scope impact <sup>p. 43</sup>.
* ''Short-term technical margin'' +EUR 60m to EUR 479m, including the recapture of Laya <sup>p. 43</sup>.
* ''Gross earned premiums'' +10% to EUR 17,416m <sup>p. 43</sup>.
* ''All year combined ratio'' 97.2%, improved 0.1pts <sup>p. 43</sup>.
* ''Long-term technical margin'' +EUR 156m to EUR 2,804m <sup>p. 43</sup>.
** ''CSM release'' +EUR 215m to EUR 2,954m <sup>p. 43</sup>.
** ''Technical experience'' decreased EUR 58m to EUR -150m <sup>p. 43</sup>.
* ''Investment income'' (non-VFA only) decreased EUR 1m to EUR 2,484m <sup>p. 43</sup>.
** ''Average assets'' (FY25) at EUR 98bn with an asset book yield of 2.5% and FY25 reinvestment yield on fixed income assets of 3.8% <sup>p. 43</sup>.
* ''Insurance finance expenses'' (non-VFA only) increased EUR 9m to EUR -1,538m <sup>p. 43</sup>.
** ''Reserves at locked-in rate'' (FY24) at EUR 62bn with a liability book yield of 2.5% <sup>p. 43</sup>.
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Technical Resultand (Lifefinancial &results Health)in Euro million, pre-tax <sup>p. 43</sup>
! style="text-align:left" | EURTechnical millionand Financial Results
! class="col-s" style="text-align:right" | ValueFY25
! class="col-s" style="text-align:right" | Change
|-
Line 1,798 ⟶ 1,611:
| style="text-align:right" | 2,804
| style="text-align:right" | +156
|}
</div>
 
* Includes recapture of Laya
* Gross Earned Premiums: EUR 17,416 (+10%)
* All Year Combined Ratio: 97.2% (-0.1pts)
* CSM release: EUR 2,954 (+EUR 215)
* Technical experience: -EUR 150 (-EUR 58)
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Life & Health FY25 CSM Key Sensitivities <sup>p. 43</sup>
! style="text-align:left" | Scenario
! class="col-s" style="text-align:right" | EUR billion
|-
| style="text-align:left" | Baseline
| style="text-align:right" | 33.3
|-
| style="text-align:left" | Interest rates +50bps
| style="text-align:right" | -0.8
|-
| style="text-align:left" | Interest rates -50bps
| style="text-align:right" | 0.6
|-
| style="text-align:left" | Sovereign spreads +50bps
| style="text-align:right" | -1.9
|-
| style="text-align:left" | Sovereign spreads -50bps
| style="text-align:right" | 1.9
|-
| style="text-align:left" | Corporate spread +50bps
| style="text-align:right" | -0.8
|-
| style="text-align:left" | Corporate spread -50bps
| style="text-align:right" | 0.8
|-
| style="text-align:left" | Equities +25%
| style="text-align:right" | 1.8
|-
| style="text-align:left" | Equities -25%
| style="text-align:right" | -2.2
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Financial Result (Life & Health) <sup>p. 43</sup>
! style="text-align:left" | EUR million
! class="col-s" style="text-align:right" | Value
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Investment Income (non-VFA only)
Line 1,858 ⟶ 1,621:
|}
</div>
 
* FY25 Average Assets: EUR 98bn
* Asset book yield: 2.5%
* FY25 Reinvestment yield¹: 3.8%
* FY24 Reserves at locked-in rate: EUR 62bn
* Liability book yield: 2.5%
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying Earningsearnings (Lifebridge &in Health)Euro million <sup>p. 43</sup>
! style="text-align:left" | EURUnderlying millionEarnings
! class="col-s" style="text-align:right" | ValueFY25
! class="col-s" style="text-align:right" | Change
|-
Line 1,878 ⟶ 1,635:
| style="text-align:left" | Tax
| style="text-align:right" | -800
| style="text-align:right" | +65
|-
| style="text-align:left" | Affiliates, Minority interests & Other
Line 1,890 ⟶ 1,647:
</div>
 
* Growth''Underlying vs.earnings growth'' +7% versus FY24 (at constant FX): +7%<sup>p. 43</sup>.
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ InvestedLife assets& Health FY25 CSM key sensitivities in Euro billion <sup>p. 43</sup>
! style="text-align:left" | EUR billionSensitivity
! class="col-s" style="text-align:right" | ValueImpact
! class="col-s" style="text-align:right" | Share of total G/A portfolio
|-
| style="text-align:left" | Residential MortgagesBaseline
| style="text-align:right" | 1633.3
| style="text-align:right" | 4%
|-
| style="text-align:left" | CLOInterest &rates ABS+50bps
| style="text-align:right" | 25-0.8
| style="text-align:right" | 6%
|-
| style="text-align:left" | InfrastructureInterest debtrates -50bps
| style="text-align:right" | 80.6
| style="text-align:right" | 2%
|-
| style="text-align:left" | CRESovereign debtspreads +50bps
| style="text-align:right" | 8-1.9
| style="text-align:right" | 2%
|-
| style="text-align:left" | Mid-MarketSovereign lendingspreads -50bps
| style="text-align:right" | 101.9
| style="text-align:right" | 2%
|-
| style="text-align:left" | OtherCorporate spread +50bps
| style="text-align:right" | 2-0.8
| style="text-align:right" | 0%
|-
| style="text-align:left; font-weight:bold" | TotalCorporate Structuredspread and Private Credit Assets-50bps
| style="text-align:right; font-weight:bold" | 690.7
|-
| style="text-align:right; font-weight:bold" | 15%
| style="text-align:left" | Equities +25%
| style="text-align:right" | 1.8
|-
| style="text-align:left" | Equities -25%
| style="text-align:right" | -2.2
|}
</div>
 
=== Table of contents ===
* EUR 6bn Dutch mortgages, NHG guaranteed
 
* EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV)
* ''Debt and Invested Assets'' <sup>p. 31</sup>
* 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA)
* ''Additional P&C disclosures'' <sup>p. 36</sup>
* Skewed towards resilient industries (Telecom, Utilities, Transport)
* ''Additional IFRS17 disclosures'' <sup>p. 41</sup>
* Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV
* ''Sustainability'' <sup>p. 44</sup>
* Strong diversification with EUR 8m average ticket
* Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation
* o/w 54% participating
* (flow) '''Technical Result''' (in EUR million, pre-tax) <sup>p. 43</sup>
* (flow) '''Financial Result''' (in EUR million, pre-tax) <sup>p. 43</sup>
 
=== Expanding AXA's role in society: AXA for Progress Index 1 ===
Line 1,944 ⟶ 1,695:
<div style="overflow-x:auto">
{| class="wikitable"
|+ AXA Group 2025 ESG targets and resultsachievements <sup>p. 45</sup>
! style="text-align:left" | Category
! class="col-m" style="text-align:right" | Target
! class="col-m" style="text-align:right" | 2025Achieved Resultin 2025
! class="col-m" style="text-align:right" | Unit
|-
| style="text-align:left" | '''As a Global INVESTOR'''
| class="col-m" style="text-align:right" | —
| class="col-m" style="text-align:right" | —
| class="col-m" style="text-align:right" | —
|-
| style="text-align:left" | Climate transition financing
| class="col-m" style="text-align:right" | 5EUR 5bn per year
| class="col-m" style="text-align:right" | EUR 6.44bn
| class="col-m" style="text-align:right" | EUR bn
|-
| style="text-align:left" | Community resilience financing
| class="col-m" style="text-align:right" | 500>EUR 500m per year
| class="col-m" style="text-align:right" | EUR 1.44bn
| class="col-m" style="text-align:right" | EUR m / EUR bn
|-
| style="text-align:left" | '''AsTransition aunderwriting Global(cumulative INSURER'''2024-2026)
| class="col-m" style="text-align:right" | EUR 6bn in P&C GWP
| class="col-m" style="text-align:right" | EUR 4.6bn
| class="col-m" style="text-align:right" | —
|-
| style="text-align:left" | P&CClimate GWPadaptation to support transition underwritingsolutions (cumulative 2024-2026)
| class="col-m" style="text-align:right" | 6
| class="col-m" style="text-align:right" | 4.6
| class="col-m" style="text-align:right" | EUR bn
|-
| style="text-align:left" | Climate adaptation solutions & services (cumulative 2024-2026)
| class="col-m" style="text-align:right" | >20,000
| class="col-m" style="text-align:right" | 19,698 Cumulative(cumulative 2024-2025)
| class="col-m" style="text-align:right" | count
|-
| style="text-align:left" | Inclusive insurance customers by 2026
| class="col-m" style="text-align:right" | >2020m by 2026
| class="col-m" style="text-align:right" | 20.66m
| class="col-m" style="text-align:right" | m
|-
| style="text-align:left" | '''AsClimate aadaptation COMPANY'''training
| class="col-m" style="text-align:right" | >80,000 employees by 2026
| class="col-m" style="text-align:right" | —
| class="col-m" style="text-align:right" | —
|-
| style="text-align:left" | AXA Group employees trained on climate adaptation by 2026
| class="col-m" style="text-align:right" | >80,000
| class="col-m" style="text-align:right" | 46,420
| class="col-m" style="text-align:right" | count
|-
| style="text-align:left" | Net-Zero absolute carbonCarbon emissions by 2030reduction
| class="col-m" style="text-align:right" | -50% by 2030
| class="col-m" style="text-align:right" | -64% Reduction against 2019
| class="col-m" style="text-align:right" | %
|-
| style="text-align:left" | Percentage of AXA Group employees engaged inEmployee volunteering activities by 2026
| class="col-m" style="text-align:right" | 50% of employees by 2026
| class="col-m" style="text-align:right" | 56%
| class="col-m" style="text-align:right" | %
|}
</div>
 
* Footnote 7: Variation of AXA Group absolute carbon emissions (scope: energy Scopes 1 and 2, car fleet and business travel). Timeframe: 2019-2030. <sup>p. 45</sup>
* Footnote 8: Carbon credits from projects that focus on capturing and storing carbon emissions from the atmosphere using nature-based or technical solutions (e.g. restorative agriculture, forest restoration or carbon capture and storage). <sup>p. 45</sup>
 
=== Sustainability Performance & Ratings ===
Line 2,014 ⟶ 1,738:
<div style="overflow-x:auto">
{| class="wikitable"
|+ AXA Group ESG ratings and scores, 2025 <sup>p. 46</sup>
! style="text-align:left" | Rating Agency
! class="col-ms" style="text-align:right" | 2025 Score / Rating
|-
| style="text-align:left" | S&P Global
| class="col-m" style="text-align:right" | 97th percentile (Dow Jones Best-in-Class Europe & World indices)
|-
| style="text-align:left" | S&P Global percentile
| class="col-ms" style="text-align:right" | AAA97th
|-
| style="text-align:left" | MSCI
| class="col-ms" style="text-align:right" | AAA
|-
| style="text-align:left" | CDP
| class="col-ms" style="text-align:right" | B
|-
| style="text-align:left" | Morningstar Sustainalytics
| class="col-ms" style="text-align:right" | 17.0 - Low risk
|-
| style="text-align:left" | FTSE Russell
| class="col-ms" style="text-align:right" | 4.3/5 (FTSE4Good Index Series)
|}
</div>
 
* The Corporate Sustainability Assessment (CSA) ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (more preciselyspecifically AXA Restricted Shares), with results as of February 6th, 2026 <sup>p. 46</sup>.
* Results''Morningstar asSustainalytics rating'': 2025 ESG Risk Rating of February17.0 6th, 2026Low risk <sup>p. 46</sup>.
* ''FTSE Russell score'': 4.3/5 in FTSE4Good Index Series <sup>p. 46</sup>
 
=== Scope ===
 
* '''France''': scope includes insurance activities, banking activities, and holding <sup>p. 47</sup>.
* '''Europe''': scope includes Switzerland (insurance activities), Germany (insurance activities and holding), Belgium and Luxemburg (insurance activities and holding), United Kingdom and Ireland (insurance activities and holding), Spain (insurance activities and holdings), Italy (insurance activities), Prima (insurance activities), and AXA Life Europe (insurance activities) <sup>p. 47</sup>.
* '''AXA XL''': scope includes insurance and reinsurance activities and holding <sup>p. 47</sup>.
* '''Asia, Africa & EME-LATAM''': <sup>p.scope 47</sup>includes:
** '''Asia''': Japan (insurance activities and holding), Hong Kong (insurance activities), Thailand P&C, China P&C, South Korea, and Asia Holdings which are fully consolidated; China L&S, Thailand L&S, the Philippines L&S and P&C, Indonesia L&S, and India (Life activities disposed on March 11, 2024 and holding) businesses which are consolidated under the equity method and contribute only to NBV, PVEP, the underlying earnings, and net income <sup>p. 47</sup>.
** China''Africa'': L&S,Morocco Thailand(insurance activities L&Sand holding), theNigeria Philippines(insurance L&Sactivities and P&Cholding), Indonesia L&S and IndiaEgypt (Lifeinsurance activities disposed on March 11, 2024 and holding) businesses which are fully consolidated under the equity method and contribute only to NBV, PVEP, the underlying earnings and net income <sup>p. 47</sup>.
** '''Africa'EME-LATAM'': MoroccoMexico (insurance activities), andColombia holding)(insurance andactivities), NigeriaBrazil (insurance activities and holding), Egyptand Türkiye (insurance activities and holding) which are fully consolidated, as well as Russia (Reso) (insurance activities) which is consolidated under the equity method and contributes only to net income <sup>p. 47</sup>.
** ''AXA Mediterranean Holdings'' <sup>p. 47</sup>.
** '''EME-LATAM''': Mexico (insurance activities), Colombia (insurance activities), Brazil (insurance activities and holding) and Türkiye (insurance activities and holding) which are fully consolidated <sup>p. 47</sup>.
** Russia''Transversal (Reso)& (insuranceOther'' activities)scope whichincludes consolidatedAXA underAssistance, theAXA equityLiabilities methodManagers, AXA, and contributes only to theother netCentral incomeHoldings <sup>p. 47</sup>.
* ''AXA Investment Managers'' (until July 1, 2025) scope includes AXA Investment Managers, Select (previously referred to as Architas), and Capza which are fully consolidated, and Asian joint ventures which are consolidated under the equity method <sup>p. 47</sup>.
** AXA Mediterranean Holdings <sup>p. 47</sup>.
* ''Accounting standards'' comparative figures going back to 2023 are under IFRS17/9 standards (effective January 1, 2023); figures prior to 2023 have not been restated and are presented under IFRS4 <sup>p. 47</sup>.
* '''Transversal & Other''': includes AXA Assistance, AXA Liabilities Managers, AXA and other Central Holdings <sup>p. 47</sup>.
* '''AXA Investment Managers (until July 1, 2025)''': includes AXA Investment Managers, Select (previously referred to as Architas) and Capza which are fully consolidated and Asian joint ventures which are consolidated under the equity method <sup>p. 47</sup>.
* Unless otherwise specified, all comparative figures for going back to 2023 are under the IFRS17/9 accounting standards that became effective on January 1, 2023 <sup>p. 47</sup>.
* Figures for financial periods prior to 2023 have not been restated under IFRS17/9 and are presented under IFRS4, the applicable accounting standard that preceded the implementation of IFRS17/9 <sup>p. 47</sup>.
 
=== Glossary ===
 
* '''Capital-light G/A products''': encompass all products with no guarantees, with guarantees at maturity only or with guarantees equal to or lower than 0% <sup>p. 48</sup>.
* '''Contractual Service Margin (CSM)''': a component of the carrying amount of asset or liability for a group of insurance contracts representing the unearned profit to be recognized as services are provided to policyholders <sup>p. 48</sup>.
* '''CSM release''': a portion of CSM stock net of reinsurance at the end of the defined period flowing through profit and loss representing the estimated profit earned by the insurer for providing insurance services during the reporting period <sup>p. 48</sup>.
* '''Economic variance''': corresponds to the variance of the year-end CSM arising from changes in market conditions, net of the underlying return on in-force <sup>p. 48</sup>.
* '''Financial result''': consists of investment income on assets backing BBA and PAA contracts as well as assets backing shareholder's equity, net of the insurance finance expenses (IFE) defined as the unwind of the present value of future cash flow <sup>p. 48</sup>.
* '''Gross Written Premiums and Other Revenues (GWP & Other Revenues)''': represent the insurance premiums collected during the period (including risk premiums, premiums from pure investment contracts with no discretionary participating features, fees and revenues, net of commissions paid on assumed reinsurance business). Other Revenues represent premiums and fees collected on activities other than insurance (i.e. banking, services, and asset management activities) <sup>p. 48</sup>.
* ''New Business Value (NBV)'': the value of newly issued contracts during the current year. It consists of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period, carried by Life entities, considering expected renewals, (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes and (vi) minority interests <sup>p. 48</sup>
* '''Other Revenues''': represent premiums and fees collected on activities other than insurance (i.e. banking, services, and asset management activities) <sup>p. 48</sup>.
* '''New Business ValueContractual Service Margin (NBVNB CSM)''': a component of the valuecarrying amount of the asset or liability for newly issued insurance contracts during the currentperiod, yearrepresenting the unearned profit to be recognized as insurance contract services are provided <sup>p. 48</sup>.
* ''New Business Value margin (NBV margin)'': ratio of (i) NBV, representing the value of newly issued contracts during the current year, to (ii) PVEP <sup>p. 48</sup>
** It consists of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period, carried by Life entities, considering expected renewals, (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes and (vi) minority interests <sup>p. 48</sup>.
* ''Operating variance'': the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes. Operating variance is net of reinsurance <sup>p. 48</sup>
* '''New Business Contractual Service Margin (NB CSM)''': a component of the carrying amount of the asset or liability for newly issued insurance contracts during the period, representing the unearned profit to be recognized as insurance contract services are provided <sup>p. 48</sup>.
* '''NewPresent Businessvalue Valueof marginexpected (NBVpremiums margin(PVEP)''': ratiothe ofnew (i)business NBVvolume, representingequal to the present value ofat newlythe issuedtime contractsof duringissue of the currenttotal year,premiums expected to (ii)be received over the policy term. PVEP is discounted at the reference interest rate and PVEP is Group share <sup>p. 48</sup>.
* '''OperatingTechnical variance'experience'': the variationconsists of the year-endimpacts CSM versuson the expectedunderlying atearnings opening due toof (i) the differencesdifference between realizedthe expected and expectedincurred cash-flows of the operationaldefined assumptionsperiod, (ii) changesthe inrisk assumptionsadjustment suchrelease, as(iii) mortality,the longevity,changes lapsesin andonerous expensescontracts, and (iiiiv) impactthe other long-term elements which are mainly composed of modelnon-attributable changesexpenses <sup>p. 48</sup>.
* ''Underlying return on in-force'': represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance <sup>p. 48</sup>
** Operating variance is net of reinsurance <sup>p. 48</sup>.
* '''Present value of expected premiums (PVEP)''': the new business volume, equal to the present value at the time of issue of the total premiums expected to be received over the policy term <sup>p. 48</sup>.
** PVEP is discounted at the reference interest rate and PVEP is Group share <sup>p. 48</sup>.
* '''Technical experience''': consists the impacts on the underlying earnings if (i) the difference between the expected and incurred cash-flows of the defined period, (ii) the risk adjustment release, (iii) the changes in onerous contracts, and (iv) the other long-term elements which are mainly composed of non-attributable expenses <sup>p. 48</sup>.
* '''Underlying return on in-force''': represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance <sup>p. 48</sup>.
 
=== February 26, 2026 Thank you Full Year 2025 earnings ===
 
* ''Closing slide'' for the AXA Full Year 2025 Earnings presentation, dated February 26, 2026 <sup>p. 49</sup>.
* Thank you <sup>p. 49</sup>.
* Full Year 2025 Earnings <sup>p. 49</sup>.
* February 26, 2026 <sup>p. 49</sup>.
 
== Abbreviations ==
 
* '''AA''': Senior Securedbond rating
* '''AAA''': Senior Securedbond rating
* '''ABS''': Asset-Backed Securities
* '''AEP''': Aggregate Exceedance Probability
* '''AI''': Artificial Intelligence
* '''AMF''': Autorité des Marchésmarchés Financiersfinanciers
* '''APAC''': Asia-Pacific
* '''AXA IM''': AXA Investment Managers
* ''AXA XL'': AXA Corporate Solutions and XL Catlin
* '''AY''': Accident Year
* '''BBA'AY'': Bearer BondAccident AccountYear
* '''CLO'BBA'': Collateralized LoanBenefit-Bearing ObligationAccount
* '''CRE'CDP'': CommercialCarbon RealDisclosure EstateProject
* '''CSM'CLO'': ContractualCollateralized ServiceLoan MarginObligation
* '''CY'CRE'': CalendarCommercial Real YearEstate
* '''DPS'CSA'': DividendCorporate PerSustainability ShareAssessment
* '''EME'CSM'': Europe,Contractual MiddleService EastMargin
* '''EOF'CY'': Eligible OwnCalendar FundsYear
* '''EPS'DPS'': EarningsDividend Per Share
* ''EME'': Emerging Markets
* '''ESG''': Environmental, Social, and Governance
* ''EOF'': Eligible Own Funds
* '''ESMA''': European Securities and Markets Authority
* '''EU'EPS'': EuropeanEarnings Per UnionShare
* ''ESG'': Environmental, Social, and Governance
* '''FX''': Foreign Exchange
* ''ESMA'': European Securities and Markets Authority
* '''GAAP''': Generally Accepted Accounting Principles
* '''GEP'EU'': Gross EarnedEuropean PremiumsUnion
* '''GF EUR''': Green Finance Euro
* ''FX'': Foreign Exchange
* '''GF GBP''': Green Finance Great British Pound
* ''GAAP'': Generally Accepted Accounting Principles
* '''GWP''': Gross Written Premiums
* '''HKD'GBP'': HongGreat KongBritish DollarPound
* '''HY'GEP'': HighGross Earned YieldPremium
* '''IFE'GWP'': InsuranceGross FinanceWritten ExpensesPremiums
* ''HKD'': Hong Kong Dollar
* '''IFRS''': International Financial Reporting Standards
* '''IG'HY'': InvestmentHigh GradeYield
* '''JPY'IFE'': JapaneseInsurance Finance YenExpenses
* ''IFRS'': International Financial Reporting Standards
* '''LATAM''': Latin America
* '''LTV'IG'': Loan-To-ValueInvestment Grade
* ''JPY'': Japanese Yen
* '''MSCI''': Morgan Stanley Capital International
* '''MX'LATAM'': MexicoLatin America
* '''NA'LFL'': North AmericaLike-for-Like
* ''LTV'': Loan-to-Value
* '''NB CSM''': New Business Contractual Service Margin
* ''MSCI'': Morgan Stanley Capital International
* '''NBV''': New Business Value
* '''NHG'NA'': Nationale HypotheekNorth GarantieAmerica
* ''NB CSM'': New Business Contractual Service Margin
* '''NPS''': Net Promoter Score
* '''OCI'NBV'': OtherNew ComprehensiveBusiness IncomeValue
* '''PAA'NHG'': PremiumNationale AllocationHypotheek ApproachGarantie
* '''PE'NPS'': PrivateNet Promoter EquityScore
* ''OCI'': Other Comprehensive Income
* '''PVEP''': Present Value of Expected Profits
* '''PYD'PAA'': Prior Years'Participating ReserveAccount DevelopmentAgreement
* '''RCG'PE'': Reinsurance Cost ofPrivate GuaranteesEquity
* '''ROE'PVEP'': ReturnPresent Value of OnExpected EquityProfits
* '''SCR'PYD'': SolvencyPrior Years' CapitalReserve RequirementDevelopment
* '''SHE'RCG'': Shareholders'Reinsurance Capital EquityGeneration
* '''SME'ROE'': Small andReturn Medium-sizedon EnterprisesEquity
* ''SCR'': Solvency Capital Requirement
* '''TVOG''': Time Value of Options & Guarantees
* '''UEPS'SHE'': Underlying Earnings PerShareholders' ShareEquity
* ''SME'': Small and Medium-sized Enterprises
* '''UK''': United Kingdom
* ''TVOG'': Time Value of Options and Guarantees
* '''US''': United States
* '''VAT'UEPS'': ValueUnderlying Earnings AddedPer TaxShare
* '''VFA'UK'': Variable FeeUnited ApproachKingdom
* ''US'': United States
* ''VAT'': Value Added Tax
* ''VFA'': Variable Fee Approach